homocysteine has been researched along with fibrinogen in 250 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.40) | 18.7374 |
1990's | 17 (6.80) | 18.2507 |
2000's | 147 (58.80) | 29.6817 |
2010's | 72 (28.80) | 24.3611 |
2020's | 13 (5.20) | 2.80 |
Authors | Studies |
---|---|
Berg, K; Kierulf, P; Malinow, MR; Upson, B | 1 |
Kim, S | 1 |
Assmann, G; Heinrich, J; Köhler, E; Malinow, MR; Schönfeld, R; Schulte, H; Upson, B; von Eckardstein, A | 1 |
Bønaa, KH; Joakimsen, O; Leren, TP; Ose, L; Russell, D; Stensland-Bugge, E; Tonstad, S | 1 |
Bausserman, L; Bostom, AG; Jacques, PF; Lapane, KL; Nadeau, MR; Rosenberg, IH; Selhub, J; Shemin, D; Sutherland, P; Tofler, G; Wilson, PW; Yoburn, D | 1 |
Abbate, R; Gensini, GF; Micheli, S; Prisco, D | 1 |
Donner, MG; Klein, GK; Mathes, PB; Richter, WO; Schwandt, P | 1 |
Kaplan, R; Rao, AK; Sheth, S | 1 |
Kronenberg, F | 1 |
Allen, R; Contois, JH; Ens, G; Giri, S; Otvos, J; Taxel, P; Thompson, PD; Waters, DD; Wu, AH | 1 |
Berg, K | 1 |
Wanner, C; Zimmermann, J | 1 |
Titus, K | 1 |
Ridker, PM | 2 |
Assmann, G; Bobak, M; Bui, M; Fobker, M; Gostomzyk, J; Hense, HW; Junker, R; Kark, J; Kuch, B; Marmot, M; Schulte, H; Sinnreich, R; Vojtisek, P; von Eckardstein, A | 1 |
Harjai, KJ | 1 |
Assmann, G; Breithardt, G; Cullen, P; Erren, M; Fobker, M; Junker, R; Kerber, S; Kropf, J; Reinecke, H; Schulte, H; Schurek, JO | 1 |
Beattie, DK; Davies, AH; Greenhalgh, RM; Sian, M | 1 |
Anderson, PW; Cox, DA; Dean, RA; Paul, S; Tracy, RP; Walsh, BW; Wild, RA | 1 |
Cristofani, R; De Pietro, S; Metelli, MR; Migliori, M; Palla, R; Panichi, V; Perez, R; Rindi, P; Taccola, D; Tetta, C | 1 |
Dardik, R; Salomon, O; Savion, N; Shenkman, B; Tamarin, I; Varon, D; Zivelin, A | 1 |
Backhouse, O; Lee, D; Mahomed, I; Parapia, L | 1 |
Gau, GT; Kullo, IJ; Tajik, AJ | 1 |
Mikhailidis, DP; Milionis, HJ; Winder, AF | 1 |
Benedetto, FA; Fermo, I; Focà, A; Malatino, LS; Mallamaci, F; Paroni, R; Tripepi, G; Zoccali, C | 1 |
Chi, HS; Jung, HH; Kim, SB; Min, WK; Park, JS; Yang, WS | 1 |
Massy, ZA | 1 |
Feuerstein, IM; Hunt, ME; O'Malley, PG; Taylor, AJ; Vernalis, MN | 1 |
Atwal, AS; Davis, M; Hamilton, G; Jagroop, IA; Mikhailidis, DP; Nair, DR; Seifalian, AM | 1 |
Bukowska, H; Dziewanowski, K; Klinke, M; Naruszewicz, M; Staniewicz, A | 1 |
Ridker, PM; Rifai, N; Stampfer, MJ | 1 |
Bogaty, P; Boyer, L; Dagenais, GR; Poirier, P; Simard, S; Solymoss, S | 1 |
Bobak, M; Fobker, M; Hense, HW; Junker, R; Kuch, B; Marmot, M; von Eckardstein, A | 1 |
de Gaetano, G; Donati, MB; Iacoviello, L | 1 |
Brzósko, S; Hryszko, T; Małyszko, J; Myśliwiec, M; Pawlak, K; Łebkowska, U | 1 |
Gladdish, S; Rajkumar, C | 1 |
Chan, NN; Chow, FC | 1 |
Goodson, N | 1 |
Erkelens, DW; Roeters van Lennep, JE; van der Wall, EE; Westerveld, HT | 1 |
Acevedo, M; Cross, JA; Foody, JM; Frolkis, JP; Hoogwerf, BJ; Pashkow, FJ; Pearce, GL; Robinson, K; Sprecher, DL; Vidt, DG | 1 |
Lip, GY; Makin, A; Silverman, SH | 1 |
Kade, G; Prokopiuk, M; Wańkowicz, Z; Wierzbicki, P | 1 |
Bukowska, H; Chelstowski, K; Honczarenko, K; Jastrzebska, M; Naruszewicz, M; Torbus-Lisiecka, B | 1 |
Acevedo, M; Kottke-Marchant, K; Pearce, GL; Sprecher, DL | 1 |
Anaya, F; Andrés, A; Arias, M; Campistol, JM; Capdevila, L; del Castillo, D; Escuín, F; Gil Vernet, JM; González Molina, M; Grinyo, JM; Lampreave, I; Marcén, R; Morales, JM; Oppenheimer, F; Pallardó, L; Valdés, F | 1 |
Cienfuegos, JA; de Irala, J; Diez-Caballero, A; Frühbeck, G; Gil, MJ; Gómez-Ambrosi, J; Orbe, J; Páramo, JA; Salvador, J | 1 |
Brzósko, S; Małyszko, J; Małyszko, JS; Myśliwiec, M; Pawlak, K | 1 |
Barban, A; Bonaccorsi, G; Donegà, P; Fellin, R; Mollica, G; Pansini, F; Passaro, A; Vigna, GB; Zanca, R | 1 |
El-Hazmi, MA | 1 |
Ashton, EL; Liew, D; Magliano, DJ; McNeil, JJ; Sundararajan, V | 1 |
Auer, J; Berent, R; Eber, B; Lassnig, E; Rammer, M; Weber, T | 1 |
Cevik, C; Göldeli, E; Güneri, S; Savaş, S; Soysal, D; Sözmen, E; Susam, I | 1 |
Chmiel, G; Drozdz, M; Klimeczek, P; Konieczyńska, M; Kowalczyk-Michałek, M; Kraśniak, A; Pasowicz, M; Podolec, P; Sułowicz, W; Szumilak, D; Tracz, W; Wicher-Muniak, E | 1 |
Geleijnse, JM; Giltay, EJ; Gooren, LJ; Schouten, EG; Stehouwer, CD; Verhoef, P | 1 |
Imai, Y; Nagai, R | 1 |
Alver, A; Cimşit, G; Orem, A; Uydu, HA; Vanizor Kural, B; Yandi, YE | 1 |
Bazzano, LA; He, J; Muntner, P; Vupputuri, S; Whelton, PK | 1 |
Crimmins, EM; Hayward, M; Johnston, M; Seeman, T | 1 |
Ballantyne, CM; Boland, LL; Chambless, LE; Desvarieux, M; Folsom, AR; Nieto, FJ | 1 |
Hoffman, M; Sauls, DL; Wolberg, AS | 1 |
Arya, R; Asonganyi, B; Ford, E; Jackson, SH; Mangoni, AA; Ouldred, E; Sherwood, RA; Swift, CG | 1 |
Galar, M; Głowińska, B; Koput, A; Urban, M | 1 |
Minagawa, T; Oda, H; Ohashi, H; Ohkuma, T; Ohno, M; Takada, N | 1 |
Berg, K; Eikvar, L; Retterstol, L | 1 |
Anand, SS; Hackam, DG | 1 |
Akalin, S; Akpinar, I; Deyneli, O; Gözü, H; Haklar, G; Sezgin, O; Yavuz, D; Yildiz, E | 1 |
Balk, EM; Goudas, LC; Jordan, HS; Karas, RH; Kim, LU; Kupelnick, B; Lau, J | 1 |
Carrillo, E; Lanes, R; Palacios, A; Paoli, M; Villaroel, O | 1 |
Chen, J; Hamm, LL; He, J; Kusek, JW; Muntner, P; Whelton, PK | 1 |
Chrysohoou, C; Masoura, C; Panagiotakos, DB; Pitsavos, C; Skoumas, J; Stefanadis, C; Toutouzas, P | 1 |
Berent, H; Dutkiewicz-Raczkowska, M; Kuczyńska, K; Symonides, B; Wocial, B | 1 |
Afzali, B; Bakri, RS; Bharma-Ariza, P; Covic, A; Crook, MA; Dalton, N; Goldsmith, DJ; Park, WH; Sriharan, M; Sriskantharan, R; Wierzbicki, AS | 1 |
von Eckardstein, A | 1 |
Brönstrup, A; Burger, M; Mensink, G; Pietrzik, K; Thierfelder, W | 1 |
Cieślik, G; Idzior-Waluś, B; Sieradzki, J; Waluś, M | 1 |
Beevers, GD; Blann, AD; Felmeden, DC; Lip, GY; Martin, SC; Spencer, CG | 1 |
Homer-Vaniasinkam, S; Naseem, KM; Nicolaou, A; Riba, R; Troxler, M | 1 |
Ikeda, T; Kobayashi, S; Kumagai, H; Moriya, H; Ohtake, T | 1 |
Celińska-Löwenhoff, M; Undas, A | 1 |
Chrysohoou, C; Das, UN; Panagiotakos, DB; Pitsavos, C; Stefanadis, C | 1 |
Christodoulou, G; Chrysohoou, C; Panagiotakos, DB; Papageorgiou, C; Pitsavos, C; Stefanadis, C; Tsetsekou, E | 1 |
Ben Abdallah, T; Ben Maiz, H; Feki, H; Feki, M; Fellah, H; Kaabachi, N; Lacour, B; Massy, ZA; Mebazaa, A; Souissi, M | 1 |
Fomin, VV; Kopeleva, MV; Martynov, AI; Moiseev, SV; Mukhin, NA; Paramonov, AD; Stankevich, LI | 1 |
Amundsen, SR; Aune, S; Dregelid, E; Eide, GE; Jenssen, GL; Jonung, T; Laxdal, E; Pedersen, G; Wirsching, J | 1 |
Aso, Y; Inukai, T; Matsutomo, R; Okumura, K; Takebayashi, K; Wakabayashi, S; Yoshida, N | 1 |
Antoniades, C; Brown, M; Chrysohoou, C; Panagiotakos, DB; Pitsavos, C; Skoumas, J; Stefanadis, C | 1 |
Ghosh, K; Khare, A; Kulkarni, B; Mohanty, D; Shetty, S | 1 |
Dobordzhginidze, LM | 1 |
Pilgeram, L | 1 |
Bertomeu, V; Bodí, V; Chorro, FJ; Fácila, L; Llàcer, A; Núñez, J; Pellicer, M; Sanchis, J | 1 |
Cases, A | 1 |
Ballantyne, CM; Kullo, IJ | 1 |
Charvát, J; Chlumský, J; Kvapil, M; Michalová, K; Táborská, K; Vojácek, J | 1 |
Oliveira, GH | 1 |
Ansquer, JC; Foucher, C; Rattier, S; Steiner, G; Taskinen, MR | 1 |
Burge, MR; Colleran, KM; Romero, LA; Upton, DA | 1 |
Choumerianou, D; Chrysohoou, C; Dedoussis, GV; Panagiotakos, DB; Pitsavos, C; Skoumas, J; Stefanadis, C | 1 |
Bertomeu, V; Bodí, V; Chorro, FJ; Fácila, L; Llàcer, A; Núñez, J; Pellicer, M; Ruiz, V; Sanchis, J | 1 |
Gau, G | 1 |
Panagiotakos, DB; Papageorgiou, C; Pitsavos, C; Soldatos, C; Stefanadis, C; Tsetsekou, E | 1 |
Anglés-Cano, E; Durlach, V; Nardulli, M; Pepe, G | 1 |
Hitoglou-Makedou, AD; Kazakos, KA; Lasaridis, AN; Mouslech, TF; Nilsson, PM; Sarafidis, PA; Stafylas, PC; Tourkantonis, AA; Yovos, JG | 1 |
Bukowska, H; Honczarenko, K; Jastrzebska, M; Mierzecki, A; Naruszewicz, M | 1 |
Albertini, F; Archetti, S; Assanelli, D; Galeazzi, G; Grassi, M; Mozzini, C; Negrini, R; Pezzini, A; Salvadori, G | 1 |
Bukowska, H; Honczarenko, K; Jastrzebska, M; Mierzecki, A; Millo, B; Torbus-Lisiecka, B | 1 |
Binder, L; Budde, T; Dobos, GJ; Kannenberg, F; Knoblauch, NT; Lehmann, N; Michalsen, A; Moebus, S; Pithan, C | 1 |
Amundsen, SR; Aune, S; Bertz, A; Dregelid, E; Jonung, T; Laxdal, E; Nyheim, T; Pedersen, G; Wirsching, J | 1 |
Langhorne, P; Lowe, GD; MacDonald, JB; MacFarlane, PW; MacIntosh, G; McMahon, AD; O'Reilly, DS; Rumley, A; Spilg, EG; Stott, DJ; Tait, RC; Westendorp, RG | 1 |
Fujioka, T; Kadota, J; Tamura, A | 1 |
Kelly, GS | 1 |
Franz, M; Grønbaek, M; Jensen, MK; Koh-Banerjee, P; Rimm, EB; Sampson, L | 1 |
Kannel, WB | 1 |
Hoffman, M; Lenkowski, A; Lockhart, E; Sauls, DL; Warren, ME; Wilhelm, SE | 1 |
Buring, JE; Lee, IM; Mora, S; Ridker, PM | 1 |
Dichgans, M; Gschwendtner, A; Herzog, J; Holtmannspötter, M; Opherk, C; Peters, N; Sämann, P | 1 |
Benzi, L; Cuccuru, I; Del Prato, S; Di Cianni, G; Ghio, A; Lencioni, C; Miccoli, R; Pellegrini, G; Volpe, L | 1 |
Gullu, S; Gursoy, A; Kamel, N; Ozduman Cin, M | 1 |
Hiramoto, JS; Lane, JS; Lane, KT; Messina, LM; Vittinghoff, E | 1 |
Bolaman, Z; Kadikoylu, G; Ozgel, N; Yenisey, C | 1 |
Aktürk, M; Altinova, AE; Arslan, M; Ayvaz, G; Bukan, N; Cakir, N; Törüner, FB | 1 |
Bornstein, J; Dourleshter, G; Fait, V; German, L; Hirsh, Y; Ophir, E | 1 |
Al-Amin, H; Beaini, M; Daher, R; Usta, I | 1 |
Demkow, M; Dzielińska, Z; Florczak, E; Janas, J; Januszewicz, A; Januszewicz, M; Kadziela, J; Makowiecka-Cieśla, M; Naruszewicz, M; Nowicka, G; Prejbisz, A; Ruzyłło, W; Zieliński, T | 1 |
Britton, J; Venn, A | 1 |
Cushman, M; Jenny, NS; Katz, R; Psaty, BM; Reiner, AP; Schwartz, SM; Zakai, NA | 1 |
Fatourou, EM; Hamilton, G; Mikhailidis, DP; Paraskevas, KI; Seifalian, AM | 1 |
Albert, MA; Buring, JE; Glynn, RJ; Ridker, PM | 1 |
Mahato, B; Muennig, P; Sohler, N | 1 |
Jakubowski, H; Sikora, M; Twardowski, T | 1 |
Bailey, KR; Kardia, SL; Khawaja, FJ; Kullo, IJ; Mosley, TH; Turner, ST | 1 |
Barr, RG; Bertoni, AG; Jacobs, DR; Jenny, NS; Nettleton, JA; Schulze, MB; Steffen, LM | 1 |
Aral, Y; Cakal, B; Cakal, E; Demirbaş, B; Karaahmetoğlu, S; Ozkaya, M; Serter, R | 1 |
Papadimitriou, DK; Pitoulias, GA; Tachtsi, MD; Tsiaousis, PZ | 1 |
Jakubowski, H | 3 |
Akalin, A; Alatas, O; Colak, O | 1 |
Archetti, S; Assanelli, D; Grassi, M; Kisialiou, A; Mozzini, C; Pezzini, A | 1 |
Albert, MA | 1 |
Carvajal, Z; Marchi, R; Weisel, JW | 1 |
Aydemir, B; Gulyasar, T; Gunes, P; Kiziler, AR; Unal, E | 1 |
Battaglia, C; Cianciosi, A; de Aloysio, D; Facchinetti, F; Mancini, F; Reggiani, GM | 1 |
Arheart, KL; Clark, JD; Dietz, NA; Fleming, LE; LeBlanc, WG; Lee, DJ; Wilkinson, JD | 1 |
Cho, L; Hazen, SL; Hoogwerf, BJ; Lauer, MS; Oliveira, LP; Shishehbor, MH; Sprecher, DL; Wolski, K | 1 |
Franchini, M; Guidi, GC; Lippi, G; Montagnana, M; Salvagno, GL; Targher, G | 1 |
Burke, GL; Jacobs, DR; Jenny, NS; Jiang, R; Nettleton, JA; Schulze, MB | 1 |
Hoffman, M | 1 |
Boers, GH; Jakubowski, H; Strauss, KA | 1 |
de Kraker, AT; Kenemans, P; Kroeks, MV; Smolders, RG; van der Mooren, MJ | 1 |
Benjamin, EJ; Jacques, PF; Larson, MG; Levy, D; Lieb, W; Mitchell, GF; Selhub, J; Tofler, GH; Vasan, RS; Vita, JA; Wang, TJ; Yin, X | 1 |
Akar, N; Deda, G; Ertem, M; Teber, S; Unal, O | 1 |
del Rey Sánchez, JM; Escobar-Morreale, HF; Luque-Ramírez, M; Matíes, M; Mendieta-Azcona, C | 1 |
Gnyp, W; Grela, W; Koszowski, B; Sobczak, A; Szołtysek-Bołdys, I; Zielińska-Danch, W | 1 |
Coresh, J; Fox, CS; Muntner, P; Uribarri, J; Vupputuri, S | 1 |
Benjamin, EJ; D'Agostino, RB; Hayes, L; Jacques, P; Joseph, J; Levy, D; Pencina, MJ; Selhub, J; Tofler, GH; Vasan, RS; Wang, TJ | 1 |
Karatela, RA; Sainani, GS | 1 |
Arhan, E; Guven, A; Köse, G; Ozaydin, E; Sayli, TR; Unal, B | 1 |
Almasy, L; Andersen, M; Barlera, S; Blanco-Vaca, F; Buil, A; Clarke, R; Fontcuberta, J; Hamsten, A; Mälarstig, A; Peden, J; Seedorf, U; Silveira, A; Soria, JM; Souto, JC; Watkins, H | 1 |
Ahmadinejad, M; Atabak, S; Hedayati, M; Imani, H; Rahmani, L; Tabibi, H | 1 |
Bingol, B; Biri, A; Gunenc, Z; Güner, H; Tiras, B; Yilmaz, M | 1 |
Kordich, L; Lauricella, AM; Oberholzer, MV; Quintana, IL | 1 |
Catena, C; Cavarape, A; Colussi, G; De Marchi, S; Dotto, L; Novehllo, M; Sechi, LA | 1 |
Demidova, VS; Doguzhieva, RM; Egorova, VV; Emel'ianov, DR; Lebedeva, AN; Pokrovskiĭ, AV; Titova, MI | 1 |
Aybay, C; Biberoğlu, G; Ezgü, F; Hasanoglu, A; Ozbay, F; Tümer, L | 1 |
Panagiotakos, DB; Vardavas, CI | 1 |
Chang, MH; Dowling, NF; Fan, AZ; Fang, J; Hayes, D; House, M; Mokdad, AH; Ned, R; Yesupriya, A | 1 |
Chrysohoou, C; Kalogeropoulos, N; Panagiotakos, DB; Pitsavos, C; Rousinou, G; Stefanadis, C; Toutouza, M | 1 |
Acemoglu, H; Baygutalp, F; Karatay, S; Kiziltunc, A; Ugur, M; Uyanik, A; Uzkeser, H; Yildirim, K | 1 |
Böhmer, AE; Brum, LM; Hansel, G; Portela, LV; Souza, DG; Souza, DO | 1 |
Binici, DN; Borazan, A | 1 |
Criado, PR; Di Giacomo, TB; Hussein, TP; Souza, DG | 1 |
Amato, A; Cini, M; Conti, E; Favaretto, E; Legnani, C; Palareti, G; Sartori, M | 1 |
Bates, CJ; Hamer, M; Mansoor, MA; Mishra, GD; Pentieva, KD | 1 |
Chung, WS; Ihm, SH; Kim, DB; Kim, HY; Kim, JH; Lee, JM; Park, CS; Seung, KB; Yoo, KD | 1 |
Bukowska, H; Chełstowski, K; Honczarenko, K; Jastrzębska, M; Kozłowska-Wojciechowska, M; Makarewicz-Wujec, M; Masztalewicz, M; Mierzecki, A | 1 |
Dent, TH | 1 |
Hardersen, R; Hovland, A; Lappegård, KT; Mollnes, TE; Nielsen, EW | 1 |
Malinowska, J; Olas, B | 2 |
Didelez, V; Meng, S; Sheehan, NA | 1 |
Malinowska, J; Nowak, P; Olas, B | 1 |
Alemzadeh, R; Babar, GS; Daoud, M; Das, E; Hoffmann, RG; Widlansky, ME; Zidan, H | 1 |
Hoffman, M; Sauls, DL; Warren, M | 1 |
Khalil, A; Khalil, S; Mallika, V; Mandal, K | 1 |
Badiou, S; Bargnoux, AS; Canaud, B; Cristol, JP; Dupuy, AM; Jaussent, I; Klouche, K; Leray-Moragues, H; Morena, M; Patrier, L | 1 |
Garg, A | 1 |
Calcaterra, V; de Silvestri, A; Gamba, G; Lanati, G; Larizza, D; Montani, N; Terulla, V | 1 |
Agrawal, A; Gupta, BK; Gupta, R; Khatri, M; Panwar, RB; Raja, S; Vaishnav, J | 1 |
Micozkadıoğlu, H; Ozelsancak, R; Torun, D; Yiğit, F | 1 |
Conti, E; Favaretto, E; Frascaro, M; Legnani, C; Palareti, G; Sartori, M | 1 |
Majumder, PP; Mallik, S | 1 |
Babicz, K; Malinowska, J; Olas, B; Oleszek, W; Stochmal, A | 1 |
Cho, DY; Kim, BT; Kim, KM; Kim, KN; Lee, DJ | 1 |
Demidova, VS; Doguzhieva, RM; Lebedeva, AN; Pokrovskiĭ, AV | 1 |
Arheart, K; Clark, JD; Fleming, LE; Lee, DJ; Serdar, B; Wilkinson, JD | 1 |
Malinowska, J; Olas, B; Tomczynska, M | 1 |
Brosolo, G; Catena, C; Colussi, G; Sechi, LA | 1 |
Malinowska, J; Olas, B; Oleszek, W; Stochmal, A | 1 |
Gialernios, T; Karpanou, E; Kyvelou, SM; Stefanadis, C; Tzamou, V; Vyssoulis, G | 1 |
Chrudinová, M; Demianová, Z; Jiráček, J; Kořínek, M; Mládková, J; Selicharová, I | 1 |
Araki, Y; Fujita, K; Hojo, Y; Ichikawa, S; Iwasaki, T; Kanai, H; Kasama, S; Kumakura, H; Minami, K; Nakashima, K; Sumino, H; Takayama, Y | 1 |
Bargagli, E; Bianchi, N; Cappelli, R; Madioni, C; Refini, RM; Rottoli, P | 1 |
Farid, E; Megahed, H; Saleh, N; Samir, N | 1 |
Barbieri, F; Bruzzese, D; Capalbo, D; Di Mase, R; Esposito, A; Mattace Raso, G; Meli, R; Salerno, M | 1 |
Bostan, C; Kaya, A; Ozkan, AA; Uzunhasan, I; Yigit, Z; Yildiz, A | 1 |
Akalin, A; Arabul, M; Celik, M; Cerrah, S | 1 |
Aryan, Z; Esteghamati, A; Nakhjavani, M | 1 |
Alba, A; Cámara, R; Giménez, C; Hernández-Mijares, A; Rubio, O; Sarnago, A; Vayá, A | 1 |
Mykhaĭlenko, OIu | 1 |
Losada, M; Manresa, N; Mulero, J; Zafrilla, P | 1 |
de Lange, Z; Nienaber-Rousseau, C; Pieters, M | 1 |
Nowak, P; Tadeusiewicz, J | 1 |
Alama, MN; Almehdar, HA; Alzahrani, AS; Damanhouri, GA; Firoz, CK; Jabir, NR; Kamal, MA; Khan, W; Tabrez, S | 1 |
Gilowski, W; Krysiak, R; Okopien, B; Szkrobka, W | 1 |
Akalin, N; Akay, H; Erturk, K; Harmankaya, O; Kaptanogullari, H; Kocoglu, H; Okuturlar, Y | 1 |
Harichandrakumari, KT; Murugesan, V; Pulimamidi, VK; Rajappa, M; Revathy, G; Satheesh, S | 1 |
Gilowski, W; Krysiak, R; Okopien, B | 1 |
Dabass, A; Holguin, F; Marsh, GM; Rager, J; Sharma, RK; Talbott, EO; Venkat, A | 1 |
Beilin, LJ; Burke, V; Hodgson, JM; Mori, TA; Puddey, IB; Zilkens, RR | 1 |
Adamovski, M; Bernal, RT; da Silva, NN; Debortoli, G; Gonçalves, Mde C; Mastroeni, MF; Mastroeni, SS; Rondó, PH; Veugelers, PJ | 1 |
Akhvlediani, M; Baramidze, A; Gachechiladze, D; Todua, F; Tsivtsivadze, G; Vorobiova, E | 1 |
Cai, RW; Chen, YF; Huang, YH; Li, JJ; Li, MM; Lin, YY | 1 |
Acien, AN; Al Rifai, M; Barr, GR; Benjamin, EJ; Bhatnagar, A; Blaha, MJ; DeFilippis, AP; Hall, ME; Jones, MR; Keith, R; Magid, HS; McEvoy, JW; Robertson, RM; Rodriguez, CJ | 1 |
Andel, R; Handing, EP; Kumar, N; McEvoy, CL; Small, BJ | 1 |
Eggett, DL; Han, X; Parker, TL | 1 |
Ahluwalia, J; Das, R; Dogra, RK; Jamwal, M; Rohit, MK; Sharma, P; Vishwajeet, V | 1 |
Baldessari, A; Genoud, V; Gionco, S; Quintana, I; Quintana, PG | 1 |
Colak, E; Dimitrijevic-Sreckovic, V; Gacic, J; Janeski, H; Janeski, N; Mrdovic, I; Soldatovic, I; Srećković, B; Sumarac-Dumanovic, M | 1 |
Kontek, B; Olas, B; Oleszek, W; Stochmal, A | 1 |
Krysiak, R; Okopień, B; Szkróbka, W | 2 |
Farmakis, DT; Karkalousos, PL; Karpanou, EA; Lampropoulos, KM; Megalou, A; Papingiotis, G; Triantafyllou, AI; Triantafyllou, EA | 1 |
Persil-Ozkan, O; Yigit, E; Yigit, Z | 1 |
Bednarska-Czerwińska, A; Kowalcze, K; Krysiak, R; Okopień, B | 1 |
Bai, L; Du, Y; Han, K; Lu, Q; Wang, TZ; Zhu, WJ | 1 |
Cao, P; Chan, L; Chan, P; Chang, Z; Chao, Y; Chen, Z; Deng, B; Lyu, Q; Pan, Y; Que, R; Tan, EK; Wang, Q; Wang, T; Wang, Y; Xu, L; Yang, W; Yenari, MA; Yuan, F; Zhu, S | 1 |
Akcay, YY; Cetinkalp, S; Sengoz Coskun, NS; Simsir, IY | 1 |
Margolin, E; Nicholson, P; Patel, TJ; Zaslavsky, K | 1 |
Araki, M; Chou, S; Das, S; Dijkstra, J; Ishibashi, M; Jang, IK; Kawamoto, H; Kobayashi, K; Kurita, N; Kuter, D; Lee, H; Matsuoka, S; McNulty, I; Mitomo, S; Naganuma, T; Nakajima, A; Nakamura, S; Okutsu, M; Onishi, H; Seegers, LM; Tahara, S; Tanaka, K; Watanabe, Y; Yabushita, H; Yuki, H | 1 |
Kowalcze, K; Krysiak, R; Okopień, B | 1 |
Araki, M; Chou, S; Dijkstra, J; Ishibashi, M; Jang, IK; Kawamoto, H; Kobayashi, K; Kurita, N; Kuter, DJ; Lee, H; Libby, P; Matsuoka, S; McNulty, I; Mitomo, S; Naganuma, T; Nakajima, A; Nakamura, S; Okutsu, M; Onishi, H; Ouchi, T; Sato, T; Seegers, LM; Tahara, S; Tanaka, K; Watanabe, Y; Yabushita, H; Yuki, H | 1 |
Bodunova, NA; Dudina, GA; Kagramanova, AV; Knyazev, OV; Li, IA; Lishchinskaya, AA; Noskova, KK; Parfenov, AI; Sabelnikova, EA | 1 |
Han, Y; Jiang, D; Wang, H; Wu, P; Zhang, H; Zhang, J; Zong, Y | 1 |
Cheng, FW; Ford, NA; Tracy, R; Wood, AC | 1 |
Cui, S; Li, S; Zhang, C; Zhu, X | 1 |
Wang, P; Yang, Z; Yin, X | 1 |
Arietti, V; De Cecco, F; Liberale, C; Monzani, D; Nocini, R; Palma, S; Sacchetto, L; Segato, E | 1 |
44 review(s) available for homocysteine and fibrinogen
Article | Year |
---|---|
Menopause and risk of cardiovascular disease.
Topics: Adult; Aged; Animals; Antioxidants; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Cohort Studies; Coronary Artery Disease; Diet; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens; Female; Fibrinogen; Follow-Up Studies; Glucose; Hemostasis; Homocysteine; Humans; Incidence; Lipid Metabolism; Menopause; Middle Aged; Ovary; Risk; Risk Factors; Vitamins | 1996 |
Inherited hypercoagulable states.
Topics: Antithrombin III Deficiency; Blood Coagulation Disorders; Female; Fibrinogen; Fibrinolysis; Genetic Variation; Homocysteine; Humans; Male; Mutation; Pregnancy; Protein C; Prothrombin; Risk Factors; Thromboembolism | 1997 |
Homocysteine, lipoprotein(a) and fibrinogen: metabolic risk factors for cardiovascular complications of chronic renal disease.
Topics: Arteriosclerosis; Cardiovascular Diseases; Chronic Disease; Fibrinogen; Folic Acid; Homocysteine; Humans; Kidney Diseases; Lipoprotein(a); Risk Factors | 1998 |
[Molecular biology in the diagnosis of cardiovascular diseases].
Topics: Biomarkers; Cardiovascular Diseases; DNA Mutational Analysis; Fibrinogen; Genetic Variation; Homocysteine; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Molecular Biology; Polymorphism, Genetic; Risk Factors | 1998 |
Causes of coronary heart disease in patients on renal replacement therapy.
Topics: Animals; Apolipoproteins B; Coronary Disease; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Kidney Failure, Chronic; Lipoprotein(a); Renal Dialysis; Risk Factors | 1998 |
A panorama of cardiac risk.
Topics: Adult; Aged; Amyloid; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Prospective Studies; Research; Retrospective Studies; Risk Factors; Time Factors; Triglycerides; Vitamin E | 1999 |
Evaluating novel cardiovascular risk factors: can we better predict heart attacks?
Topics: Biomarkers; C-Reactive Protein; Fibrinogen; Homocysteine; Humans; Lipoprotein(a); Myocardial Infarction; Reproducibility of Results; Risk Factors; Tissue Plasminogen Activator | 1999 |
Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, lipoprotein(a), triglycerides, oxidative stress, and fibrinogen.
Topics: Cardiovascular Diseases; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Hypertriglyceridemia; Hypertrophy, Left Ventricular; Lipoprotein(a); Oxidative Stress; Risk Factors; Triglycerides | 1999 |
Novel risk factors and markers for coronary disease.
Topics: Biomarkers; C-Reactive Protein; Coronary Disease; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Hyperhomocysteinemia; Lipoprotein(a); Risk Factors; Thrombophilia; Vasculitis | 2000 |
Novel risk factors for atherosclerosis.
Topics: Arteriosclerosis; Biomarkers; Blood Coagulation Disorders; Blood Platelets; C-Reactive Protein; Cholesterol, LDL; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Infections; Inflammation; Intercellular Adhesion Molecule-1; Lipoprotein(a); Risk Factors | 2000 |
Lipoprotein (a) and stroke.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Cross-Sectional Studies; Female; Fibrinogen; Homocysteine; Humans; Lipids; Lipoprotein(a); Male; Middle Aged; Prospective Studies; Risk Factors; Stroke | 2000 |
Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patients.
Topics: Arteriosclerosis; Biomarkers; Fibrinogen; Glycation End Products, Advanced; Homocysteine; Humans; Lipoprotein(a); Risk Factors; Uremia | 2000 |
Prevention of cardiac disease in the elderly.
Topics: Aged; Diabetes Complications; Exercise; Fibrinogen; Heart Diseases; Homocysteine; Humans; Hypertension; Lipids; Obesity; Risk Factors; Smoking Cessation; United Kingdom; Vitamin E | 2001 |
Coronary artery disease and rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; C-Reactive Protein; Comorbidity; Coronary Artery Disease; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Hypertension; Risk Factors; Smoking; Survival Analysis; Survival Rate | 2002 |
Risk factors for coronary heart disease: implications of gender.
Topics: Aged; Bacterial Infections; Biomarkers; C-Reactive Protein; Coronary Disease; Diabetes Complications; Estrogens; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Inflammation; Lipid Metabolism; Male; Middle Aged; Obesity; Psychosocial Deprivation; Risk Factors; Sex; Smoking; Triglycerides | 2002 |
Peripheral vascular disease and Virchow's triad for thrombogenesis.
Topics: Arteries; Blood Coagulation Disorders; Blood Coagulation Factors; Fibrin Fibrinogen Degradation Products; Fibrinogen; Homocysteine; Humans; Peripheral Vascular Diseases; Regional Blood Flow; Thrombosis | 2002 |
[Prevention of cardiovascular risk in renal transplantation. Consensus document].
Topics: Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Diabetes Complications; Diet; Exercise; Fibrinogen; Homocysteine; Humans; Kidney Transplantation; Obesity; Risk Factors; Smoking | 2002 |
Hematological risk factors for coronary heart disease.
Topics: Antithrombins; Bacterial Infections; Coronary Disease; Factor V; Factor VIII; Fibrinogen; Homocysteine; Humans; Mutation; Plasminogen Activator Inhibitor 1; Protein C; Protein S; Prothrombin; Risk Factors | 2002 |
Novel biomedical risk markers for cardiovascular disease.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cell Adhesion Molecules; Fibrinogen; Homocysteine; Humans; Interleukin-6; Natriuretic Peptide, Brain; Risk Factors; von Willebrand Factor | 2003 |
[New biochemical and genetic risk factors for coronary artery diseases].
Topics: Aryldialkylphosphatase; Biomarkers; Blood Coagulation Factors; C-Reactive Protein; Cholesterol, HDL; Coronary Artery Disease; Esterases; Fibrinogen; Homocysteine; Humans; Insulin Resistance; Lipoprotein(a); Lipoproteins, LDL; Nitric Oxide Synthase; Plasminogen Activator Inhibitor 1; Platelet Membrane Glycoproteins; Polymorphism, Genetic; Renin-Angiotensin System; Risk Factors | 2003 |
Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence.
Topics: Arteriosclerosis; C-Reactive Protein; Fibrinogen; Homocysteine; Humans; Lipoprotein(a); Mass Screening; Risk Factors | 2003 |
Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Fibrinogen; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Plasminogen Inactivators; Platelet Aggregation; Tissue Plasminogen Activator | 2003 |
Is there a need for novel cardiovascular risk factors?
Topics: Albuminuria; Apolipoproteins A; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Homocysteine; Humans; Risk Assessment | 2004 |
[Nonlipid effects of fibrates].
Topics: C-Reactive Protein; Cytokines; Fibrinogen; Homocysteine; Humans; Hypolipidemic Agents; Insulin Resistance; Intercellular Adhesion Molecule-1; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A | 2004 |
[Fibrates: mechanism of action, effect on levels of lipids and risk of coronary events. II. Fenofibrate].
Topics: Adult; Aged; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fenofibrate; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Placebos; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Triglycerides | 2004 |
[New cardiovascular risk factors and chronic kidney disease. Hypertrophy of the left ventricle. Atrial fibrillation. Smoking. Obesity. Emerging cardiovascular risk factors: homocysteine, Reactive C protein. Fibrinogen].
Topics: Atrial Fibrillation; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Obesity; Risk Factors; Smoking | 2004 |
Conditional risk factors for atherosclerosis.
Topics: Arteriosclerosis; C-Reactive Protein; Fibrinogen; Homocysteine; Humans; Lipoprotein(a); Lipoproteins, LDL; Particle Size; Risk Factors | 2005 |
Novel serologic markers of cardiovascular risk.
Topics: Antioxidants; Aspirin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cause of Death; Cytokines; Drug Resistance; Fibrinogen; Homocysteine; Humans; Platelet Aggregation Inhibitors; Risk Factors; Survival Rate | 2005 |
[Coronary artery disease and H. pylori eradication].
Topics: Arteriosclerosis; C-Reactive Protein; Cholesterol, HDL; Coronary Artery Disease; Cytokines; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans; Inflammation Mediators | 2005 |
Overview of hemostatic factors involved in atherosclerotic cardiovascular disease.
Topics: Atherosclerosis; C-Reactive Protein; Cholesterol, LDL; Female; Fibrinogen; Fibrinolysis; Hemostasis; Homocysteine; Humans; Inflammation Mediators; Male; Risk Factors | 2005 |
The role of established and emerging risk factors in peripheral vascular graft occlusion.
Topics: C-Reactive Protein; Cholesterol; Coronary Artery Bypass; Diabetes Mellitus; Fibrinogen; Graft Occlusion, Vascular; Homocysteine; Humans; Hypertension; Lipoprotein(a); Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk Factors; Smoking; Vascular Surgical Procedures | 2007 |
[The role of homocysteine thiolactone in some of human diseases].
Topics: Animals; Aryldialkylphosphatase; Atherosclerosis; Biomarkers; Fibrinogen; Folic Acid; Homocysteine; Humans; Lipoproteins, HDL; Rabbits; Stroke; Vitamin B 12; Vitamin B 6 | 2006 |
The molecular basis of homocysteine thiolactone-mediated vascular disease.
Topics: Fibrinogen; Homocysteine; Humans; Immunity, Innate; Proteins; Vascular Diseases | 2007 |
Inflammatory biomarkers, race/ethnicity and cardiovascular disease.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Ethnicity; Fibrinogen; Homocysteine; Humans; Inflammation; Inflammation Mediators; Intercellular Adhesion Molecule-1 | 2007 |
[Role of biochemical risk factors and markers for the risk of atherosclerosis].
Topics: Apolipoproteins; Atherosclerosis; Biomarkers; Blood Coagulation Factors; Chemokines; Cholesterol, HDL; Cholesterol, LDL; Fibrinogen; Homocysteine; Humans; Italy; Metalloproteases; Prevalence; Risk Assessment; Risk Factors; Triglycerides | 2008 |
Alterations of fibrinogen structure in human disease.
Topics: Fibrinogen; Glycation End Products, Advanced; Homocysteine; Protein Processing, Post-Translational; Reactive Nitrogen Species; Reactive Oxygen Species | 2008 |
The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cystathionine beta-Synthase; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Methionine-tRNA Ligase; Methylenetetrahydrofolate Reductase (NADPH2); Mice; Thrombosis; Vascular Diseases | 2008 |
The emerging risk factors for cardiovascular disease: a review of the epidemiologic evidence for lipoprotein(a), homocysteine, and fibrinogen.
Topics: Biomarkers; Cardiovascular Diseases; Epidemiologic Studies; Fibrinogen; Homocysteine; Humans; Lipoprotein(a); Oxidative Stress; Risk Factors; Seroepidemiologic Studies | 2003 |
The causal relationship between passive smoking and inflammation on the development of cardiovascular disease: a review of the evidence.
Topics: Animals; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Homocysteine; Humans; Inflammation; Nicotiana; Oxidative Stress; Risk Factors; Thrombosis; Tobacco Smoke Pollution | 2009 |
The role of paraoxonase 1 in the detoxification of homocysteine thiolactone.
Topics: Animals; Aryldialkylphosphatase; Autoimmunity; Fibrinogen; Homocysteine; Humans; Immune System; Methionine-tRNA Ligase; Mice; Mice, Transgenic; Models, Biological; Risk Factors; Thrombosis | 2010 |
Predicting the risk of coronary heart disease. II: the role of novel molecular biomarkers and genetics in estimating risk, and the future of risk prediction.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Apolipoprotein A-I; Apolipoproteins B; Apolipoproteins E; Biomarkers; C-Reactive Protein; Coronary Disease; Cystatin C; Fibrinogen; Homocysteine; Humans; Lipoproteins; Natriuretic Peptide, Brain; Risk; Risk Assessment; Risk Factors; Uric Acid | 2010 |
[The role of post-translational modification of fibrinogen in the pathogenesis of thrombosis].
Topics: Extracellular Space; Fibrin; Fibrinogen; Fibrinolysis; Glycation End Products, Advanced; Halogenation; Homocysteine; Humans; Lysine; Protein Processing, Post-Translational; Thrombosis | 2015 |
Relationship between serum homocysteine, fibrinogen, lipoprotein-a level, and peripheral arterial disease: a dose-response meta-analysis.
Topics: Fibrinogen; Homocysteine; Humans; Lipoprotein(a); Peripheral Arterial Disease | 2022 |
The Role of Fibrinogen, Homocysteine and Metabolic Syndrome's Alterations in Sudden Sensorineural Hearing Loss (SSHL): A Narrative Review.
Topics: Fibrinogen; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Homocysteine; Humans; Metabolic Syndrome | 2023 |
23 trial(s) available for homocysteine and fibrinogen
Article | Year |
---|---|
Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men.
Topics: Administration, Oral; Aged; Antithrombin III; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Estradiol; Fibrinogen; Fibrinolysis; Follow-Up Studies; Homocysteine; Humans; Lipids; Lipoprotein(a); Male; Peptide Fragments; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Prothrombin; Risk Factors; Thrombosis | 1998 |
The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial.
Topics: Aged; C-Reactive Protein; Double-Blind Method; Estrogen Replacement Therapy; Female; Fibrinogen; Homocysteine; Humans; Lipids; Middle Aged; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Risk Factors | 2000 |
Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients.
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinogen; Hemostasis; Homocysteine; Humans; Kidney Failure, Chronic; Lipids; Lipoprotein(a); Medroxyprogesterone Acetate; Middle Aged; Plasminogen Activator Inhibitor 1; Postmenopause; Renal Dialysis; Tissue Plasminogen Activator; Triglycerides; von Willebrand Factor | 2000 |
The effect of short-term lipid lowering with atorvastatin on carotid artery intima media thickness in patients with peripheral vascular disease: a pilot study.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Carotid Arteries; Cholesterol; Exercise Test; Female; Fibrinogen; Heptanoic Acids; Homocysteine; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Pilot Projects; Pyrroles; Statistics, Nonparametric; Tunica Intima; Tunica Media; Ultrasonography | 2000 |
Homocysteine, fibrinogen, and lipoprotein(a) levels are simultaneously reduced in patients with chronic renal failure treated with folic acid, pyridoxine, and cyanocobalamin.
Topics: Adult; Arteriosclerosis; Cholesterol; Creatinine; Drug Therapy, Combination; Female; Fibrinogen; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Lipoprotein(a); Male; Pyridoxine; Renal Dialysis; Risk Factors; Triglycerides; Urea; Uric Acid; Vitamin B 12; Vitamin B Complex | 2001 |
Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial.
Topics: Administration, Cutaneous; Administration, Oral; Anticholesteremic Agents; Antithrombin III; Apolipoprotein A-I; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinogen; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Lipoprotein(a); Middle Aged; Plasminogen Activator Inhibitor 1; Postmenopause; Progestins; Simvastatin; Treatment Outcome; Triglycerides | 2002 |
[Evaluation of atherosclerosis progression in patients treated repeatedly with hemodialysis].
Topics: Adult; Aged; Arteries; Arteriosclerosis; Calcium; Cholesterol, LDL; Disease Progression; Female; Fibrinogen; Homocysteine; Humans; Kidney Diseases; Male; Middle Aged; Phosphates; Renal Dialysis; Ultrasonography | 2002 |
Oral and transdermal estrogens both lower plasma total homocysteine in male-to-female transsexuals.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Androstane-3,17-diol; Biomarkers; C-Reactive Protein; Creatinine; Cyproterone Acetate; Cysteine; Estradiol; Estrogens; Female; Fibrinogen; Folic Acid; Follicle Stimulating Hormone; Homocysteine; Humans; Luteinizing Hormone; Male; Middle Aged; Randomized Controlled Trials as Topic; Serum Albumin; Statistics as Topic; Testosterone; Time Factors; Transsexualism | 2003 |
Effects of folic acid supplementation on inflammatory and thrombogenic markers in chronic smokers. A randomised controlled trial.
Topics: Adult; Biomarkers; Blood Proteins; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Folic Acid; Homocysteine; Humans; Inflammation; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Smoking; Thrombophilia; Treatment Outcome | 2003 |
Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women.
Topics: Adult; Blood Glucose; Bromocriptine; C-Reactive Protein; Cholesterol; Endothelium, Vascular; Estrogens; Female; Fibrinogen; Glucose Tolerance Test; Homocysteine; Hormone Antagonists; Humans; Hyperprolactinemia; Insulin; Insulin Resistance; Premenopause; Prolactin; Uric Acid; Vasodilation | 2003 |
Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Coagulation; Blood Pressure; C-Reactive Protein; Cholesterol, HDL; Diet, Mediterranean; Female; Fibrinogen; Greece; Heart Diseases; Homocysteine; Humans; Inflammation Mediators; Interleukin-6; Leukocyte Count; Male; Middle Aged; Reference Values; Risk Factors; Serum Amyloid A Protein; Treatment Outcome; Triglycerides; Tumor Necrosis Factor-alpha | 2004 |
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Fenofibrate; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Homocysteine; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Incidence; Male; Middle Aged; Models, Biological; Smoking; Treatment Outcome | 2005 |
The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension. An open-label observational study.
Topics: Aged; Arteriosclerosis; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Hypoglycemic Agents; Lipoprotein(a); Male; Middle Aged; Risk Factors; Risk Reduction Behavior; Rosiglitazone; Thiazolidinediones | 2005 |
Mediterranean diet has no effect on markers of inflammation and metabolic risk factors in patients with coronary artery disease.
Topics: Biomarkers; C-Reactive Protein; Coronary Artery Disease; Diet, Mediterranean; Fatty Acids; Female; Fibrinogen; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Insulin; Lipids; Male; Middle Aged; Risk Factors | 2006 |
Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease.
Topics: Aged; Analysis of Variance; Cognition; Double-Blind Method; Drug Synergism; Female; Fibrinogen; Folic Acid; Homocysteine; Humans; Male; Riboflavin; Treatment Outcome; Vascular Diseases; Vitamin B 12; Vitamin B 6; Vitamin B Complex; von Willebrand Factor | 2005 |
Effect of tibolone therapy on lipids and coagulation indices.
Topics: Antithrombin III; Blood Coagulation; Blood Coagulation Factors; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Estrogen Receptor Modulators; Female; Fibrinogen; Homocysteine; Humans; Lipid Metabolism; Lipids; Lipoprotein(a); Middle Aged; Norpregnenes; Postmenopause; Prospective Studies; Protein C; Treatment Outcome; Triglycerides | 2006 |
Short-term effects of two continuous combined oestrogen-progestogen therapies on several cardiovascular risk markers in healthy postmenopausal women: a randomised controlled trial.
Topics: Adult; alpha-2-Antiplasmin; Antigens; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Drug Combinations; Dydrogesterone; Endothelin-1; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrinogen; Fibrinolysin; Homocysteine; Humans; Insulin-Like Growth Factor I; Medroxyprogesterone Acetate; Middle Aged; Plasminogen Activator Inhibitor 1; Postmenopause; Risk Factors; Time Factors; Tissue Plasminogen Activator | 2009 |
Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking.
Topics: Adult; Androgen Antagonists; Blood Coagulation; Blood Platelets; Case-Control Studies; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Endothelium, Vascular; Ethinyl Estradiol; Female; Fibrinogen; Homocysteine; Humans; Hypoglycemic Agents; Metformin; Obesity; Partial Thromboplastin Time; Polycystic Ovary Syndrome; Prothrombin; Smoking; Young Adult | 2009 |
Effects of soy consumption on oxidative stress, blood homocysteine, coagulation factors, and phosphorus in peritoneal dialysis patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Coagulation Factors; Factor IX; Female; Fibrinogen; Homocysteine; Humans; Iran; Kidney Failure, Chronic; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Peritoneal Dialysis; Phosphorus; Risk Factors; Soy Foods; Soybean Proteins; Thrombosis | 2009 |
Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women.
Topics: Biomarkers; Blood Glucose; C-Reactive Protein; Carbohydrate Metabolism; Cardiovascular Diseases; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Lipid Metabolism; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Risk Factors | 2010 |
The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia.
Topics: Adult; Atorvastatin; Bromocriptine; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diet; Dopamine Agonists; Exercise; Female; Fibrinogen; Homocysteine; Humans; Hypercholesterolemia; Hyperprolactinemia; Hypoglycemic Agents; Hypolipidemic Agents; Metformin; Middle Aged; Premenopause; Risk Factors; Uric Acid | 2015 |
The effects of alcohol on ambulatory blood pressure and other cardiovascular risk factors in type 2 diabetes: a randomized intervention.
Topics: Aged; Alcohol Drinking; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Heart Rate; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Wine | 2016 |
Different Effects of Atorvastatin on Cardiometabolic Risk Factors in Young Women With and Without Hyperprolactinemia.
Topics: Adult; Atorvastatin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperprolactinemia; Lipids; Metabolic Diseases; Middle Aged; Prolactin; Risk Factors | 2019 |
183 other study(ies) available for homocysteine and fibrinogen
Article | Year |
---|---|
Population variation and genetics of plasma homocyst(e)ine level.
Topics: Adult; Analysis of Variance; Apolipoproteins; Coronary Disease; Female; Fibrinogen; Homocysteine; Homocystine; Humans; Lipids; Male; Middle Aged; Norway; Twins; Twins, Dizygotic; Twins, Monozygotic | 1992 |
S-adenosylmethionine: protein-carboxyl methyltransferase from erythrocyte.
Topics: Animals; Carbon Radioisotopes; Chromatography, Gel; Chromatography, Ion Exchange; Erythrocytes; Fibrinogen; gamma-Globulins; Homocysteine; Humans; Hydrogen-Ion Concentration; Isoelectric Focusing; Kinetics; Male; Methyltransferases; Molecular Weight; Proteins; S-Adenosylmethionine; Species Specificity; Thymus Gland | 1974 |
Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men.
Topics: Adult; Age Factors; Blood Viscosity; Coronary Disease; Fibrinogen; Homocysteine; Humans; Lipoproteins; Male; Middle Aged; Risk Factors | 1994 |
Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects.
Topics: Adolescent; Anthropometry; Apolipoproteins B; Arteriosclerosis; Carotid Arteries; Carotid Stenosis; Child; Female; Fibrinogen; Homocysteine; Humans; Hyperlipoproteinemia Type II; Lipoprotein(a); Male; Norway; Puberty; Risk Factors; Sex Factors; Ultrasonography | 1996 |
Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study.
Topics: Adult; Age Factors; Aged; Amino Acid Metabolism, Inborn Errors; Arteriosclerosis; Biomarkers; Blood Coagulation Disorders; Case-Control Studies; Epidemiologic Factors; Female; Fibrinogen; Homocysteine; Humans; Kidney Failure, Chronic; Lipoprotein(a); Male; Middle Aged; Renal Dialysis; Risk Factors; Sex Factors | 1996 |
Plasma total homocysteine levels in patients with early-onset coronary heart disease and a low cardiovascular risk profile.
Topics: Adult; Body Constitution; Body Mass Index; Cholesterol, HDL; Coronary Disease; Cysteine; Female; Fibrinogen; Glutathione; Homocysteine; Humans; Lipoproteins; Lipoproteins, VLDL; Male; Middle Aged; Risk Factors; Sex Characteristics; Triglycerides; Uric Acid | 1998 |
An ecological study of determinants of coronary heart disease rates: a comparison of Czech, Bavarian and Israeli men.
Topics: Aged; Blood Glucose; Blood Pressure; Coronary Disease; Czechoslovakia; Fibrinogen; Germany; Homocysteine; Humans; Israel; Lipoproteins; Male; Middle Aged; Prevalence; Risk Factors; Triglycerides | 1999 |
Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries.
Topics: Acute-Phase Reaction; Adult; Aged; Arteritis; Biomarkers; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Constriction, Pathologic; Coronary Artery Disease; Female; Fibrinogen; Homocysteine; Humans; Interleukin-6; Intermittent Claudication; Logistic Models; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Popliteal Artery; Risk Assessment; Transforming Growth Factor beta; Triglycerides | 1999 |
Influence of systemic factors on pre-existing intimal hyperplasia and their effect on the outcome of infrainguinal arterial reconstruction with vein.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Blood Vessel Prosthesis Implantation; Female; Fibrinogen; Graft Rejection; Graft Survival; Homocysteine; Humans; Hyperplasia; Lipoprotein(a); Male; Middle Aged; Peripheral Vascular Diseases; Plastic Surgery Procedures; Saphenous Vein; Treatment Outcome; Tunica Intima | 1999 |
Plasma C-reactive protein in hemodialysis patients: a cross-sectional, longitudinal clinical survey.
Topics: Acute-Phase Proteins; Adult; Age Factors; Aged; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Female; Fibrinogen; Hemodiafiltration; Homocysteine; Humans; Interleukin-6; Longitudinal Studies; Male; Middle Aged; Renal Dialysis; Serum Albumin | 2000 |
Homocysteine and oxidized low density lipoprotein enhanced platelet adhesion to endothelial cells under flow conditions: distinct mechanisms of thrombogenic modulation.
Topics: Abciximab; Antibodies; Antibodies, Monoclonal; Calcium; Cell Adhesion Molecules; Endothelium, Vascular; Fibrin; Fibrinogen; Homocysteine; Humans; Immunoglobulin Fab Fragments; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; Oxidation-Reduction; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Cell Surface; Receptors, Vitronectin; Thromboplastin; Umbilical Veins | 2000 |
Familial thrombophilia and retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Antiphospholipid; Biomarkers; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Retinal Vein Occlusion; Risk Factors; Thrombophilia | 2000 |
Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients.
Topics: Adult; Aged; Antibodies, Bacterial; C-Reactive Protein; Carotid Artery Diseases; Chlamydia Infections; Chlamydophila pneumoniae; Female; Fibrinogen; Homocysteine; Humans; Immunoglobulin G; Kidney Failure, Chronic; Lipoprotein(a); Male; Membranes, Artificial; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Predictive Value of Tests; Regression Analysis; Renal Dialysis; Ultrasonography, Doppler, Color; Uremia | 2000 |
C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis.
Topics: Adult; Biomarkers; Body Mass Index; C-Reactive Protein; Calcinosis; Case-Control Studies; Cholesterol, LDL; Confidence Intervals; Coronary Artery Disease; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Middle Aged; Military Personnel; Prognosis; Prospective Studies; Risk Factors; Severity of Illness Index; Tomography, X-Ray Computed | 2001 |
Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.
Topics: Adult; Aged; Apolipoproteins; Arteriosclerosis; Biomarkers; C-Reactive Protein; Case-Control Studies; Cholesterol; Fibrinogen; Homocysteine; Humans; Likelihood Functions; Lipoprotein(a); Male; Middle Aged; Peripheral Vascular Diseases; Predictive Value of Tests; Prospective Studies; Regression Analysis; Risk Factors; Statistics, Nonparametric | 2001 |
Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina.
Topics: Angina Pectoris; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Recurrence; Tissue Plasminogen Activator; von Willebrand Factor | 2001 |
Associations between homocysteine and coagulation factors--a cross-sectional study in two populations of central Europe.
Topics: Blood Coagulation Factors; Cardiovascular Diseases; Cross-Sectional Studies; Europe; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostatics; Homocysteine; Humans; Linear Models; Male; Middle Aged; Risk Factors | 2001 |
[Novel risk factors for atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a) and cholesterol as predictors of peripheral arteriopathy].
Topics: Arteriosclerosis; Biomarkers; C-Reactive Protein; Cholesterol; Fibrinogen; Homocysteine; Humans; Lipoprotein(a); Peripheral Vascular Diseases; Risk Factors | 2001 |
Correlation between carotid intima-media thickness and hematocrit and hemoglobin values in renal transplant recipients.
Topics: Adult; Carotid Arteries; Case-Control Studies; Female; Fibrinogen; Hematocrit; Hemoglobins; Homocysteine; Humans; Immunoenzyme Techniques; Kidney Transplantation; Linear Models; Male; Middle Aged; Risk Factors; Tunica Intima; Tunica Media; Ultrasonography | 2001 |
Effects of fenofibrate and gemfibrozil on plasma homocysteine.
Topics: Fenofibrate; Fibrinogen; Gemfibrozil; Homocysteine; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2001 |
Blood glucose concentrations < or = 125 mg/dl and coronary heart disease risk.
Topics: Adult; Aged; Blood Glucose; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Prediabetic State; Risk Factors | 2002 |
[Biochemical risk factor for atherosclerosis in young men. Preliminary report].
Topics: Activities of Daily Living; Adaptation, Psychological; Adult; Arteriosclerosis; Attitude to Health; Biomarkers; Blood Glucose; C-Reactive Protein; Chlamydophila pneumoniae; Cholesterol; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Homocysteine; Humans; Life Style; Male; Physical Fitness; Risk Factors; Statistics, Nonparametric; Stress, Psychological; Triglycerides; Uric Acid | 2001 |
Lp(a), homocysteine and a family history of early ischemic cerebral stroke.
Topics: Adolescent; Adult; Brain Ischemia; Factor VII; Female; Fibrinogen; Genetic Predisposition to Disease; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Regression Analysis; Risk Factors; Severity of Illness Index; Stroke; Uric Acid | 2001 |
Elevated fibrinogen and homocysteine levels enhance the risk of mortality in patients from a high-risk preventive cardiology clinic.
Topics: Aged; Coronary Artery Disease; Cross-Sectional Studies; Female; Fibrinogen; Heart Diseases; Homocysteine; Humans; Longitudinal Studies; Male; Middle Aged; Prevalence; Regression Analysis; Risk Factors; Thrombosis | 2002 |
Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors.
Topics: Adipose Tissue; Adult; Aged; Body Composition; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Fibrinogen; Glucose; Homocysteine; Humans; Insulin Resistance; Leptin; Male; Middle Aged; Obesity; Risk Factors; Triglycerides; von Willebrand Factor | 2002 |
Effects of fluvastatin on homocysteine and serum lipids in kidney allograft recipients.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Dose-Response Relationship, Drug; Fatty Acids, Monounsaturated; Female; Fibrinogen; Fluvastatin; Homocysteine; Humans; Indoles; Kidney Transplantation; Lipids; Lipoprotein(a); Male; Middle Aged; Osmolar Concentration; Time Factors; Transplantation, Homologous; Triglycerides | 2002 |
Body iron stores and coronary atherosclerosis assessed by coronary angiography.
Topics: Age Factors; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Female; Ferritins; Fibrinogen; Homocysteine; Humans; Iron; Male; Middle Aged; Risk Factors; Severity of Illness Index; Sex Factors; Transferrin | 2002 |
The association of plasma homocysteine, coronary risk factors and serum nitrite in patients with coronary artery disease, vascular syndrome x and healthy subjects.
Topics: Adult; Aged; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Female; Fibrinogen; Homocysteine; Humans; Linear Models; Male; Metabolic Syndrome; Middle Aged; Nitrites; Odds Ratio; Risk Factors; Triglycerides; Turkey | 2003 |
Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients.
Topics: Acute-Phase Proteins; Adult; Arteriosclerosis; Autoantibodies; Biomarkers; Female; Fibrinogen; Fibronectins; Folic Acid; Homocysteine; Humans; Lipoproteins, LDL; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Psoriasis; Thrombosis; Tissue Plasminogen Activator; Vitamin B 12 | 2003 |
Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States.
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cotinine; Cross-Sectional Studies; Dose-Response Relationship, Drug; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Odds Ratio; Smoking; United States | 2003 |
Summaries for patients. Associations between smoking and newer risk factors for cardiovascular disease.
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Smoking; United States | 2003 |
Age differences in allostatic load: an index of physiological dysregulation.
Topics: Adaptation, Physiological; Adult; Aging; Biomarkers; Body Mass Index; C-Reactive Protein; Creatinine; Cross-Sectional Studies; Fibrinogen; Health Status Indicators; Health Surveys; Homocysteine; Humans; Hypertension; Middle Aged; Peak Expiratory Flow Rate; Risk Factors; Selection Bias; Serum Albumin; Stress, Physiological; United States | 2003 |
B vitamin status and inflammatory markers.
Topics: Arteriosclerosis; Biomarkers; C-Reactive Protein; Cell Adhesion Molecules; Cross-Sectional Studies; Dietary Supplements; E-Selectin; Fibrinogen; Folic Acid; Homocysteine; Humans; Inflammation; Leukocyte Count; Middle Aged; Pyridoxal Phosphate; Risk Factors; Vitamin B 6; Vitamin B Complex; von Willebrand Factor | 2003 |
Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia.
Topics: Animals; Blood Coagulation; Fibrin; Fibrinogen; Fibrinolysin; Homocysteine; Hyperhomocysteinemia; In Vitro Techniques; Microscopy, Electron, Scanning; Rabbits; Thrombosis | 2003 |
[Selected new atherosclerosis risk factors and markers of fibrinolysis in children and adolescents with obesity, hypertension and diabetes].
Topics: Adolescent; Adult; Apolipoprotein A-I; Apolipoproteins B; Biomarkers; Blood Coagulation Factors; Case-Control Studies; Child; Child, Preschool; Coronary Artery Disease; Diabetes Mellitus, Type 1; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Hypertension; Lipoprotein(a); Male; Obesity; Plasminogen Activator Inhibitor 1; Poland; Risk Factors; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2003 |
C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Chronic Disease; Cross-Sectional Studies; Cytokines; Female; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Japan; Kidney Failure, Chronic; Lipoprotein(a); Male; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis; Risk Factors; Sex Factors; Ultrasonography | 2003 |
A twin study of C-Reactive Protein compared to other risk factors for coronary heart disease.
Topics: Adult; Blood Pressure; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Coronary Disease; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Triglycerides; Twins, Monozygotic | 2003 |
Cardiovascular risk of young growth-hormone-deficient adolescents. Differences in growth-hormone-treated and untreated patients.
Topics: Adolescent; Cardiovascular Diseases; Child; Cholesterol, HDL; Cholesterol, LDL; Dietary Fats; Eating; Fasting; Female; Fibrinogen; Folic Acid; Homocysteine; Hormone Replacement Therapy; Human Growth Hormone; Humans; Male; Plasminogen Activator Inhibitor 1; Postprandial Period; Risk Assessment; Time Factors; Triglycerides; Vitamin B 12 | 2003 |
The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins B; C-Reactive Protein; Chronic Disease; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Diseases; Lipoprotein(a); Male; Middle Aged; Risk Factors | 2004 |
Summaries for patients. Associations of newer cardiac risk factors with chronic kidney disease.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins B; C-Reactive Protein; Chronic Disease; Coronary Disease; Female; Fibrinogen; Homocysteine; Humans; Kidney Diseases; Lipoprotein(a); Male; Middle Aged; Risk Factors | 2004 |
Effect of exposure to secondhand smoke on markers of inflammation: the ATTICA study.
Topics: Adult; Arteriosclerosis; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Greece; Health Surveys; Homocysteine; Humans; Inflammation Mediators; Leukocyte Count; Lipoproteins, LDL; Male; Middle Aged; Multivariate Analysis; Risk Factors; Tobacco Smoke Pollution | 2004 |
[Non-traditional atherosclerosis risk factors in patients with renal artery stenosis and hypertension].
Topics: Adult; Arteriosclerosis; Fibrinogen; Homocysteine; Humans; Hypertension, Renovascular; Lipoproteins; Plasminogen Activator Inhibitor 1; Renal Artery Obstruction; Risk Factors | 2003 |
Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation.
Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Creatinine; Female; Fibrinogen; Homocysteine; Humans; Inflammation Mediators; Kidney Transplantation; Male; Middle Aged; N-Acetylneuraminic Acid; Risk Factors | 2004 |
Alcohol consumption and its relation to cardiovascular risk factors in Germany.
Topics: Adult; Age Distribution; Aged; Alcohol Drinking; Analysis of Variance; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Germany; Health Surveys; Homocysteine; Humans; Lipids; Male; Middle Aged; Risk Factors; Sex Distribution; Smoking; Social Class | 2004 |
[Homocysteine and C-reactive protein concentrations in serum of diabetic patients].
Topics: Aged; Blood Glucose; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Lipids; Male; Middle Aged; Sex Factors; Triglycerides | 2003 |
Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Topics: Aged; Biomarkers; Clinical Trials as Topic; Coronary Disease; Cross-Sectional Studies; Endothelium, Vascular; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Male; Middle Aged; Outcome Assessment, Health Care; P-Selectin; Platelet Activation; Risk Factors; Stroke; von Willebrand Factor | 2004 |
Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels.
Topics: Adenosine Diphosphate; Aged; Blood Platelets; Fibrinogen; Flow Cytometry; Homocysteine; Humans; Intermittent Claudication; Middle Aged; Nitric Oxide; Nitric Oxide Donors; P-Selectin; Peripheral Vascular Diseases; Platelet Activation; S-Nitrosoglutathione; Sulfhydryl Compounds | 2004 |
Asymptomatic cerebral lacunae in patients with chronic kidney disease.
Topics: Anemia; Brain Infarction; Carotid Artery Diseases; Chronic Disease; Comorbidity; Creatinine; Electrocardiography; Female; Fibrinogen; Hematocrit; Homocysteine; Humans; Hypertension; Insulin; Insulin Resistance; Kidney Diseases; Kidney Function Tests; Lipoprotein(a); Magnetic Resonance Imaging; Male; Middle Aged; Obesity; Prevalence; Regression Analysis; Risk Factors; Ultrasonography | 2004 |
Increased plasma homocysteine concentrations in healthy people with hostile behavior: the ATTICA study.
Topics: Adult; Coronary Disease; Feeding Behavior; Female; Fibrinogen; Greece; Homocysteine; Hostility; Humans; Leukocyte Count; Life Style; Male; Middle Aged; Smoking | 2004 |
Classical and "non-classical" cardiovascular risk factors in Tunisian patients with end stage renal disease: prevalence and association with cardiovascular events.
Topics: Adult; Age Factors; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Fluorescence Polarization Immunoassay; Homocysteine; Humans; Hypertension; Kidney Failure, Chronic; Lipoprotein(a); Male; Risk Factors; Tunisia | 2004 |
[Hyperhomocysteinemia and acute phase proteins in various forms of ischemic heart disease].
Topics: Acute-Phase Proteins; Biomarkers; C-Reactive Protein; Echocardiography, Stress; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Ventricular Function, Left | 2004 |
Homocysteine levels, haemostatic risk factors and patency rates after endovascular treatment of the above-knee femoro-popliteal artery.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Arterial Occlusive Diseases; Biomarkers; Female; Femoral Artery; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Graft Occlusion, Vascular; Hemostasis; Homocysteine; Humans; Knee; Limb Salvage; Male; Middle Aged; Multivariate Analysis; Norway; Popliteal Artery; Prospective Studies; Reoperation; Risk Factors; Statistics as Topic; Treatment Outcome; Vascular Patency; Vascular Surgical Procedures | 2004 |
Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia.
Topics: Albuminuria; alpha-2-Antiplasmin; Biomarkers; Blood Coagulation; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Interleukin-6; Linear Models; Male; Middle Aged; Protein C | 2004 |
Evidence for association between endothelial nitric oxide synthase gene polymorphism (G894T) and inflammatory markers: the ATTICA study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Cross-Sectional Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Homocysteine; Humans; Leukocyte Count; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Point Mutation; Polymorphism, Genetic; Serum Amyloid A Protein | 2004 |
Combination of thrombophilia markers in acute myocardial infarction of the young.
Topics: Adult; Antithrombin III; Biomarkers; Coronary Angiography; Echocardiography; Electrophoresis, Polyacrylamide Gel; Factor V; Female; Fibrinogen; Homocysteine; Humans; Male; Myocardial Infarction; Point Mutation; Protein C; Risk Factors; Thrombophilia | 2004 |
History of emerging vascular disease risk factors.
Topics: Animals; Arteriosclerosis; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Methionine; Methylation; Review Literature as Topic; Risk Factors | 2004 |
Risk stratification in non-ST elevation acute coronary syndromes: predictive power of troponin I, C-reactive protein, fibrinogen and homocysteine.
Topics: Aged; C-Reactive Protein; Female; Fibrinogen; Homocysteine; Humans; Male; Myocardial Infarction; Predictive Value of Tests; Prognosis; Risk Assessment; Troponin I | 2005 |
[Relation between diabetes compensation, albuminuria and biochemical parameters and the results of stress myocardial SPECT in asymptomatic type 2 diabetics].
Topics: Albuminuria; C-Reactive Protein; Coronary Circulation; Coronary Disease; Diabetes Mellitus, Type 2; Exercise Test; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Tomography, Emission-Computed, Single-Photon; Uric Acid | 2004 |
Methimazole-induced hypothyroidism paradoxically decreases homocysteine.
Topics: Adolescent; Adult; Female; Fibrinogen; Folic Acid; Homocysteine; Humans; Hypothyroidism; Lipids; Logistic Models; Male; Methimazole; Methionine; Plasminogen Activator Inhibitor 1; Thyrotropin; Vitamin B 12; Vitamin B 6 | 2005 |
An association between the methylenetetrahydrofolate reductase (MTHFR) C677T mutation and inflammation markers related to cardiovascular disease.
Topics: C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Genotype; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Polymorphism, Genetic; Serum Amyloid A Protein | 2005 |
Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes.
Topics: Aged; Analysis of Variance; Angina, Unstable; Biomarkers; C-Reactive Protein; Electrocardiography; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myoglobin; Prognosis; Recurrence; Risk Assessment; Risk Factors; Troponin I | 2005 |
Novel risk factors for heart disease. An interview with Gerald Gau, M.D.
Topics: Biomarkers; C-Reactive Protein; Cholesterol, VLDL; Fibrinogen; Heart Diseases; Homocysteine; Humans; Lipoprotein(a); Risk Factors | 2005 |
Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anxiety; Biomarkers; Blood Coagulation; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Interleukin-6; Leukocyte Count; Male; Middle Aged; Risk Factors; Tumor Necrosis Factor-alpha | 2006 |
Mechanism for the homocysteine-enhanced antifibrinolytic potential of lipoprotein(a) in human plasma.
Topics: Antifibrinolytic Agents; Blotting, Western; Cell Line; Disulfides; Dose-Response Relationship, Drug; Fibrin; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Immunoblotting; Ligands; Lipoprotein(a); Phenotype; Plasminogen; Protein Binding; Protein Isoforms; Protein Structure, Tertiary; Recombinant Proteins; Risk Factors; Structure-Activity Relationship; Transfection | 2005 |
[Effect of low doses of folic acid on selected biochemical atherosclerosis risk factors--preliminary study].
Topics: Adult; Apolipoprotein A-I; Atherosclerosis; Cholesterol, LDL; Female; Fibrinogen; Folic Acid; Hematinics; Homocysteine; Humans; Male; Risk Factors; Time Factors | 2005 |
Modeling premature occurrence of acute coronary syndrome with atherogenic and thrombogenic risk factors and gene markers in extended families.
Topics: Age of Onset; Atherosclerosis; Family Health; Female; Fibrinogen; Genetic Markers; Genotype; Homocysteine; Humans; Male; Middle Aged; Models, Statistical; Myocardial Infarction; Pedigree; Risk Factors; Thrombosis | 2005 |
[Assessment of metabolic atherosclerosis risk factors in progeny of patients with past ischemic stroke].
Topics: Adult; Apolipoprotein A-I; Apolipoproteins B; Biomarkers; Brain Ischemia; C-Reactive Protein; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Female; Fibrinogen; Folic Acid; Genetic Predisposition to Disease; Homocysteine; Humans; Life Style; Lipoprotein(a); Male; Risk Factors; Stroke; Time Factors; Triglycerides; von Willebrand Factor | 2005 |
Homocysteine levels, haemostatic risk factors and patency rates after endovascular treatment of the common iliac arteries.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon; Atherosclerosis; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Graft Occlusion, Vascular; Hemostasis; Homocysteine; Humans; Iliac Artery; Male; Middle Aged; Multivariate Analysis; Risk Factors; Stents; Treatment Outcome; Vascular Patency; Vascular Surgical Procedures | 2006 |
Seasonal variations of selected cardiovascular risk factors.
Topics: Biomarkers; C-Reactive Protein; Cholesterol; Chronobiology Phenomena; Fibrinogen; Homocysteine; Humans; Lipids; Risk Factors; Seasons | 2005 |
Whole grains, bran, and germ in relation to homocysteine and markers of glycemic control, lipids, and inflammation 1.
Topics: Adult; Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus; Edible Grain; Female; Fibrinogen; Health Surveys; Heart Diseases; Homocysteine; Humans; Inflammation; Insulin; Interleukin-6; Leptin; Lipid Metabolism; Male; Middle Aged; Risk Factors | 2006 |
Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
Topics: Amino Acid Sequence; Blood Coagulation; Dose-Response Relationship, Drug; Fibrin; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Hyperhomocysteinemia; Lysine; Models, Biological; Molecular Sequence Data; Plasminogen; Protein Binding; Radiation-Protective Agents; Structure-Activity Relationship; Thrombosis; Tissue Plasminogen Activator | 2006 |
Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women.
Topics: Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Creatinine; Cross-Sectional Studies; Exercise; Female; Fibrinogen; Homocysteine; Humans; Intercellular Adhesion Molecule-1; Lipoproteins; Middle Aged; Overweight; Risk Factors | 2006 |
Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease.
Topics: Adult; Atrophy; Brain; CADASIL; Cognition Disorders; Comorbidity; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Hypercholesterolemia; Hypertension; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Risk Factors; Smoking | 2006 |
C-reactive protein and metabolic syndrome in women with previous gestational diabetes.
Topics: Abdomen; Adult; C-Reactive Protein; Diabetes, Gestational; Female; Fibrinogen; Homocysteine; Humans; Hyperglycemia; Lipoproteins, HDL; Metabolic Syndrome; Obesity; Parity; Pregnancy; Reference Values; Triglycerides | 2007 |
Which thyroid-stimulating hormone level should be sought in hypothyroid patients under L-thyroxine replacement therapy?
Topics: C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Fibrin Fibrinogen Degradation Products; Fibrinogen; Homocysteine; Humans; Hypothyroidism; Middle Aged; Risk Factors; Thyrotropin; Thyroxine | 2006 |
Risk factors for premature peripheral vascular disease: results for the National Health and Nutritional Survey, 1999-2002.
Topics: Age of Onset; Ankle; Blood Pressure; Brachial Artery; Coronary Artery Disease; Demography; Female; Fibrinogen; Health Surveys; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Nutrition Surveys; Peripheral Vascular Diseases; Prevalence; Risk Factors; United States | 2006 |
Effects of atorvastatin on coagulation parameters and homocysteine in patients with primary hypercholesterolemia.
Topics: Adult; Aged; Atorvastatin; Biomarkers; Blood Coagulation; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Heptanoic Acids; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Pyrroles; Treatment Outcome | 2006 |
Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism.
Topics: Adiponectin; Adult; Apolipoproteins B; Apoprotein(a); Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Female; Fibrinogen; Homocysteine; Humans; Hyperthyroidism; Hypothyroidism; Insulin Resistance; Lipoprotein(a); Male; Middle Aged; Multivariate Analysis; Risk Factors | 2006 |
Newborns of pre-eclamptic women: a biochemical difference present in utero.
Topics: Abdomen; Adult; Anthropometry; Biomarkers; Birth Weight; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Fetal Blood; Fibrinogen; Gestational Age; Homocysteine; Humans; Infant, Newborn; Lipids; Pre-Eclampsia; Pregnancy; Triglycerides | 2006 |
Cardiovascular risk factors in hypertensive patients with coronary artery disease and coexisting renal artery stenosis.
Topics: Age Factors; Aged; C-Reactive Protein; Cardiac Catheterization; Coronary Angiography; Coronary Artery Disease; Creatinine; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Male; Metabolic Clearance Rate; Middle Aged; Prevalence; Renal Artery Obstruction; Risk Factors | 2007 |
Exposure to secondhand smoke and biomarkers of cardiovascular disease risk in never-smoking adults.
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cotinine; Cross-Sectional Studies; Female; Fibrinogen; Homocysteine; Humans; Leukocyte Count; Male; Middle Aged; Risk Factors; Tobacco Smoke Pollution | 2007 |
Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study.
Topics: Aged; Aging; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cohort Studies; Factor VIII; Female; Fibrinogen; Hemostasis; Homocysteine; Humans; Inflammation Mediators; Interleukin-6; Leukocyte Count; Lipoprotein(a); Male; Prospective Studies; Risk Factors | 2007 |
Relation between soluble intercellular adhesion molecule-1, homocysteine, and fibrinogen levels and race/ethnicity in women without cardiovascular disease.
Topics: Aged; Cross-Sectional Studies; Ethnicity; Female; Fibrinogen; Health Status; Homocysteine; Humans; Intercellular Adhesion Molecule-1; Middle Aged; Postmenopause; White People | 2007 |
Socioeconomic status as an independent predictor of physiological biomarkers of cardiovascular disease: evidence from NHANES.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Educational Status; Female; Fibrinogen; Homocysteine; Humans; Income; Lipoproteins, HDL; Logistic Models; Male; Middle Aged; Nutrition Surveys; Risk Factors; Social Class; Stress, Psychological; United States | 2007 |
Association of novel risk factors with the ankle brachial index in African American and non-Hispanic white populations.
Topics: Ankle; Black or African American; C-Reactive Protein; Female; Fibrinogen; Homocysteine; Humans; Linear Models; Male; Middle Aged; Peripheral Vascular Diseases; Predictive Value of Tests; Risk Factors; White People | 2007 |
Associations between markers of subclinical atherosclerosis and dietary patterns derived by principal components analysis and reduced rank regression in the Multi-Ethnic Study of Atherosclerosis (MESA).
Topics: Aged; Aged, 80 and over; Atherosclerosis; Biomarkers; C-Reactive Protein; Calcinosis; Carotid Artery, Common; Carotid Artery, Internal; Coronary Artery Disease; Diet; Feeding Behavior; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Principal Component Analysis; Regression Analysis; Tunica Intima | 2007 |
Homocysteine and fibrinogen changes with L-thyroxine in subclinical hypothyroid patients.
Topics: Adult; Case-Control Studies; Female; Fibrinogen; Folic Acid; Homocysteine; Humans; Hypothyroidism; Kidney; Middle Aged; Thyrotropin; Thyroxine; Triiodothyronine; Vitamin B 12 | 2007 |
Hyperhomocysteinemia and hypercoagulable state in carotid plaque evolution. Novel risk factors or coincidental risk predictors?
Topics: Aged; Antithrombin III; Blood Coagulation Factors; Carotid Artery Diseases; Female; Fibrinogen; Follow-Up Studies; Greece; Homocysteine; Humans; Hyperhomocysteinemia; Immunoassay; Incidence; Male; Prognosis; Protein C; Protein S; Receptors, Cell Surface; Retrospective Studies; Risk Factors; Thrombophilia; Ultrasonography, Doppler, Duplex | 2007 |
Relation of plasma homocysteine levels to atherosclerotic vascular disease and inflammation markers in type 2 diabetic patients.
Topics: Aged; Atherosclerosis; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Fibrinogen; Homocysteine; Humans; Inflammation; Interleukin-6; Kidney Function Tests; Middle Aged; Tumor Necrosis Factor-alpha | 2008 |
Evidence of major genes effects on serum homocysteine and fibrinogen levels, and premature ischemic heart disease in Italian extended families.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fibrinogen; Genetic Predisposition to Disease; Homocysteine; Humans; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Myocardial Ischemia; Parents; Pedigree; Polymorphism, Single Nucleotide; Risk Factors; Siblings | 2008 |
Comparison of the effect of different homocysteine concentrations on clot formation using human plasma and purified fibrinogen.
Topics: Blood Coagulation; Factor XIII; Fibrin; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia | 2008 |
Relationships among iron, protein oxidation and lipid peroxidation levels in rats with alcohol-induced acute pancreatitis.
Topics: Acute Disease; Animals; Blood Viscosity; Central Nervous System Depressants; Erythrocytes; Ethanol; Fibrinogen; Glutathione; Homocysteine; Iron; Lipid Peroxidation; Male; Malondialdehyde; Oxidation-Reduction; Pancreas; Pancreatitis, Alcoholic; Protein Carbonylation; Rats; Rats, Wistar | 2008 |
Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study.
Topics: Adult; Androgens; Blood Flow Velocity; Brachial Artery; Case-Control Studies; Endothelin-1; Endothelium, Vascular; Female; Fibrinogen; Homocysteine; Humans; Insulin; Insulin Resistance; Leptin; Menstruation; Overweight; Polycystic Ovary Syndrome; Progesterone; Vasodilation; Young Adult | 2009 |
Inflammatory markers and secondhand tobacco smoke exposure among U.S. workers.
Topics: Adult; C-Reactive Protein; Cotinine; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Leukocyte Count; Male; Nutrition Surveys; Occupational Exposure; Occupations; Tobacco Smoke Pollution | 2008 |
Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease.
Topics: Biomarkers; Cardiovascular Diseases; Cause of Death; Confidence Intervals; Female; Fibrinogen; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Odds Ratio; Ohio; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Survival Rate | 2008 |
A priori-defined dietary patterns and markers of cardiovascular disease risk in the Multi-Ethnic Study of Atherosclerosis (MESA).
Topics: Aged; Aged, 80 and over; Atherosclerosis; Biomarkers; Brachial Artery; C-Reactive Protein; Cardiovascular Diseases; Carotid Artery, Common; Diet; Diet Surveys; Ethnicity; Factor Analysis, Statistical; Feeding Behavior; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Interleukin-6; Linear Models; Male; Middle Aged; Nutrition Assessment; Risk Factors; Surveys and Questionnaires; Tunica Intima; United States | 2008 |
Mutations in cystathionine beta-synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans.
Topics: Adolescent; Adult; Aged; Cystathionine beta-Synthase; Fibrinogen; Genes; Homocysteine; Homocystinuria; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation | 2008 |
Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study.
Topics: Aldosterone; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; C-Reactive Protein; Cross-Sectional Studies; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Plasminogen Activator Inhibitor 1; Protein Precursors; Renin; Renin-Angiotensin System; Risk Factors | 2009 |
Thrombophilic risk factors in epileptic children treated with valproic Acid.
Topics: Adolescent; Anticonvulsants; Antithrombin III; Blood Coagulation Factors; Child; Child, Preschool; Epilepsy; Female; Fibrinogen; Homocysteine; Humans; Infant; Lipoprotein(a); Male; Protein C; Protein S; Prothrombin; Risk Factors; Thrombophilia; Valproic Acid | 2009 |
[Novel risk factors for cardiovascular disease and tobacco smoke].
Topics: Adult; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Causality; Comorbidity; Environmental Monitoring; Epidemiological Monitoring; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Smoking; Tobacco Smoke Pollution | 2008 |
Metabolic abnormalities are present in adults with elevated serum cystatin C.
Topics: Adult; Age Factors; C-Reactive Protein; Cystatin C; Female; Fibrinogen; Glomerular Filtration Rate; Hemoglobins; Homocysteine; Humans; Hyperuricemia; Kidney Diseases; Kidney Failure, Chronic; Male; Nutrition Surveys; Phosphorus; Prevalence; Reference Values; United States | 2009 |
Cross-sectional relations of multiple biomarkers representing distinct biological pathways to plasma markers of collagen metabolism in the community.
Topics: Aged; Aldosterone; Atrial Natriuretic Factor; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Collagen; Collagen Type III; Cross-Sectional Studies; Data Collection; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Inflammation; Male; Matrix Metalloproteinase 9; Middle Aged; Natriuretic Peptide, Brain; Plasminogen Activator Inhibitor 1; Protein Precursors; Renin; Renin-Angiotensin System; Tissue Inhibitor of Metalloproteinase-1; Ventricular Remodeling | 2009 |
Plasma leptin in insulin-resistant and insulin-nonresistant coronary artery disease and its association with cardio-metabolic risk factors among Asian Indians.
Topics: Adult; Asian People; Body Mass Index; Coronary Artery Disease; Female; Fibrinogen; Glucose; Homocysteine; Humans; India; Insulin; Insulin Resistance; Leptin; Lipids; Male; Middle Aged; Risk Factors; Waist Circumference | 2009 |
Valproate-associated coagulopathies in children during short-term treatment.
Topics: Adolescent; Anticonvulsants; Biomarkers; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Protein Disorders; Child; Child, Preschool; Down-Regulation; Drug Administration Schedule; Epilepsy; Factor VII; Factor VIII; Female; Fibrinogen; Homocysteine; Humans; Lipoprotein(a); Male; Platelet Count; Prospective Studies; Protein C; Valproic Acid | 2009 |
Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Atherosclerosis; Biomarkers; Carrier Proteins; Child; Child, Preschool; Cohort Studies; Creatinine; Family; Female; Fibrinogen; Genome-Wide Association Study; Genome, Human; Homocysteine; Humans; Infant; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptor-Like Protein Tyrosine Phosphatases, Class 2; Spain; Thrombosis | 2009 |
Impaired fibrin gel permeability by high homocysteine levels.
Topics: Factor XIII; Fibrin; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Hyperhomocysteinemia; Linear Models; Permeability | 2011 |
[Assessment of the level of homocysteine and the state of haemostasis in patients with and without type 2 diabetes mellitus in remote terms after reconstructive operations on the aorto-iliac segment].
Topics: Aged; Antithrombin III; Aorta, Abdominal; Blood Vessel Prosthesis Implantation; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Homocysteine; Humans; Iliac Artery; Leg; Male; Middle Aged; Plastic Surgery Procedures; Platelet Aggregation; Postoperative Complications; Thromboplastin; Time Factors | 2009 |
Homocysteine, fibrinogen and anti-ox-LDL antibody levels as markers of atherosclerosis in prepubertal obese children.
Topics: Atherosclerosis; Autoantibodies; Biomarkers; Child; Coronary Disease; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Lipoproteins, LDL; Male; Obesity | 2009 |
Gene polymorphisms in association with emerging cardiovascular risk markers in adult women.
Topics: Adolescent; Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Demography; Female; Fibrinogen; Genotype; Homocysteine; Humans; Linear Models; Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Uric Acid | 2010 |
Unsaturated fatty acids are inversely associated and n-6/n-3 ratios are positively related to inflammation and coagulation markers in plasma of apparently healthy adults.
Topics: Adult; Biomarkers; Blood Coagulation; C-Reactive Protein; Chromatography, Gas; Dietary Supplements; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Interleukin-6; Male; Reference Values; Regression Analysis; Sensitivity and Specificity; Tumor Necrosis Factor-alpha | 2010 |
Increased serum concentrations of homocysteine and lipoprotein (a) in familial Mediterranean fever.
Topics: Adult; Blood Sedimentation; C-Reactive Protein; Familial Mediterranean Fever; Female; Fibrinogen; Folic Acid; Homocysteine; Humans; Lipoprotein(a); Male; Prognosis; Young Adult | 2010 |
Long-term cyclosporine treatment in non-transplanted rats and metabolic risk factors of vascular diseases.
Topics: Animals; Blood Coagulation; Body Weight; Cyclosporine; Fibrinogen; Glucose Tolerance Test; Homocysteine; Humans; Immunosuppressive Agents; Insulin; Leptin; Lipids; Male; Rats; Rats, Wistar; Risk Factors; Vascular Diseases | 2010 |
Relationship between insulin resistance and inflamation markers in hemodialysis patients.
Topics: Albumins; Analysis of Variance; Biomarkers; Blood Glucose; C-Reactive Protein; Female; Fibrinogen; Homocysteine; Humans; Insulin Resistance; Kidney Failure, Chronic; Lipid Metabolism; Male; Renal Dialysis; Risk Factors; Urea; Uric Acid | 2010 |
Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs--a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Anticardiolipin; Anticoagulants; Blood Coagulation Tests; Factor V; Female; Fibrinogen; Heparin; Homocysteine; Humans; Lupus Coagulation Inhibitor; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Prospective Studies; Protein C; Protein S; Prothrombin; Skin Diseases, Vascular; Thrombophilia; Warfarin; Young Adult | 2010 |
Thrombophilic risk factors and peripheral arterial disease severity.
Topics: Aged; Constriction, Pathologic; Disease Progression; DNA Mutational Analysis; Factor VIII; Female; Fibrinogen; Homocysteine; Humans; Ischemia; Lupus Coagulation Inhibitor; Male; Mutation; Peripheral Arterial Disease; Polymorphism, Genetic; Prothrombin; Risk Factors; Thrombophilia | 2010 |
Biochemical risk indices, including plasma homocysteine, that prospectively predict mortality in older British people: the National Diet and Nutrition Survey of People Aged 65 Years and Over.
Topics: Aged; Aged, 80 and over; Biomarkers; Cholesterol; Chymotrypsin; Creatinine; Diet Surveys; Dietary Proteins; Energy Intake; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Male; Mortality; Nutritional Status; Prognosis; Proportional Hazards Models; Risk Factors; Survival Analysis; United Kingdom; Vascular Diseases; Vitamin B Complex | 2010 |
Relation between C-reactive protein, homocysteine levels, fibrinogen, and lipoprotein levels and leukocyte and platelet counts, and 10-year risk for cardiovascular disease among healthy adults in the USA.
Topics: Adult; Aged; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Disease Progression; Female; Fibrinogen; Homocysteine; Humans; Incidence; Leukocyte Count; Lipoproteins; Male; Middle Aged; Platelet Count; Prognosis; Reference Values; Retrospective Studies; Risk Assessment; Risk Factors; United States | 2010 |
Does the progeny of premature ischemic stroke sufferers need intensive interest of physicians oriented toward primary prevention? A pilot study.
Topics: Adult; Age of Onset; Analysis of Variance; Biomarkers; Brain Ischemia; Case-Control Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Heredity; Homocysteine; Humans; Lipids; Logistic Models; Male; Odds Ratio; Pedigree; Phenotype; Pilot Projects; Poland; Primary Prevention; Risk Assessment; Risk Factors; Stroke; Young Adult | 2010 |
Hematologic and hemostatic changes induced by different columns during LDL apheresis.
Topics: Adult; Antithrombin III; Blood Component Removal; Cholesterol, LDL; Female; Fibrinogen; Hemostasis; Homocysteine; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Peptide Hydrolases; Plasminogen Activator Inhibitor 1 | 2010 |
Effect of resveratrol on hemostatic properties of human fibrinogen and plasma during model of hyperhomocysteinemia.
Topics: Adult; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Resveratrol; Stilbenes | 2010 |
Mendelian randomisation: a tool for assessing causality in observational epidemiology.
Topics: Alcohol Drinking; Blood Pressure; Causality; Coronary Disease; Fibrinogen; Homocysteine; Humans; Mendelian Randomization Analysis; Molecular Epidemiology; Stroke | 2011 |
Comparison of the effect of homocysteine in the reduced form, its thiolactone and protein homocysteinylation on hemostatic properties of plasma.
Topics: Adult; Blood Coagulation; Blood Proteins; Fibrinogen; Hemostasis; Homocysteine; Humans; Hyperhomocysteinemia; Lysine; Oxidation-Reduction; Sulfhydryl Compounds | 2011 |
Impaired endothelial function in preadolescent children with type 1 diabetes.
Topics: Blood Glucose; Brachial Artery; C-Reactive Protein; Carotid Arteries; Child; Diabetes Mellitus, Type 1; Endothelium, Vascular; Fasting; Female; Fibrinogen; Folic Acid; Homocysteine; Humans; Male; Tunica Intima; Tunica Media; Ultrasonography | 2011 |
Homocysteinylated fibrinogen forms disulfide-linked complexes with albumin.
Topics: Albumins; Animals; Blotting, Western; Disulfides; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Rabbits | 2011 |
Homocysteine, fibrinogen and lipid profile in children of young adults with coronary artery disease.
Topics: Adolescent; Adult; Blood Chemical Analysis; Child; Child, Preschool; Coronary Artery Disease; Fibrinogen; Homocysteine; Humans; India; Lipids; Middle Aged; Parents; Risk Factors | 2011 |
Reduced glomerular filtration rate, inflammation and HDL cholesterol as main determinants of superoxide production in non-dialysis chronic kidney disease patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Cholesterol, HDL; Creatine; Female; Fibrinogen; Glomerular Filtration Rate; Homocysteine; Humans; Inflammation; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Superoxides | 2011 |
What is the role of alternative biomarkers for coronary heart disease?
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Biomarkers; C-Reactive Protein; Coronary Disease; Fibrinogen; Homocysteine; Humans; Lipoprotein(a); Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors | 2011 |
Thrombophilic screening in Turner syndrome.
Topics: Adolescent; Adult; Antithrombin III; Comorbidity; Factor VIII; Female; Fibrinogen; Genotype; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Protein C; Protein S; Prothrombin; Thromboembolism; Thrombophilia; Turner Syndrome; Young Adult | 2011 |
Atherothrombotic risk factors & premature coronary heart disease in India: a case-control study.
Topics: Adult; Atherosclerosis; Blood Pressure; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Eating; Female; Fibrinogen; Homocysteine; Humans; India; Logistic Models; Male; Middle Aged; Platelet Count; Risk Factors; Smoking; Thrombosis; Triglycerides | 2011 |
Increased inflammatory markers are associated with obesity and not with target organ damage in newly diagnosed untreated essential hypertensive patients.
Topics: Adult; Aged; Albuminuria; Body Mass Index; C-Reactive Protein; Case-Control Studies; Cross-Sectional Studies; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Hypertrophy, Left Ventricular; Inflammation Mediators; Male; Middle Aged; Obesity; Risk Factors | 2012 |
Thrombotic risk factors and cardiovascular events after endovascular intervention for peripheral arterial disease.
Topics: Aged; Angioplasty; Cardiovascular Diseases; Factor V; Factor VIII; Female; Fibrinogen; Homocysteine; Humans; Intermittent Claudication; Ischemia; Leg; Lupus Coagulation Inhibitor; Male; Peripheral Arterial Disease; Proportional Hazards Models; Risk Factors; Stents; Thrombophilia; Thrombosis | 2011 |
Homocysteine and its thiolactone-mediated modification of fibrinogen affect blood platelet adhesion.
Topics: Adult; Blood Platelets; Fibrinogen; Hemostasis; Homocysteine; Humans; Hyperhomocysteinemia; Platelet Adhesiveness; Young Adult | 2012 |
A two-step genetic study on quantitative precursors of coronary artery disease in a homogeneous Indian population: case-control association discovery and validation by transmission-disequilibrium test.
Topics: Adult; Apolipoproteins B; Biomarkers; Case-Control Studies; Cholesterol; Coronary Artery Disease; Female; Fibrinogen; Genetic Association Studies; Homocysteine; Humans; India; Linkage Disequilibrium; Male; Middle Aged; NF-kappa B; Polymorphism, Single Nucleotide; Quantitative Trait Loci; Vascular Endothelial Growth Factor A | 2011 |
Aronia melanocarpa extract suppresses the biotoxicity of homocysteine and its metabolite on the hemostatic activity of fibrinogen and plasma.
Topics: Adult; Anticoagulants; Antioxidants; Blood Coagulation; Cardiovascular Diseases; Coagulants; Dietary Supplements; Fibrinogen; Fruit; Homocysteine; Humans; Hyperhomocysteinemia; Models, Biological; Oxidative Stress; Photinia; Plant Extracts; Poland; Polymerization; Resveratrol; Stilbenes | 2012 |
Combination of high-sensitivity C-reactive protein and homocysteine may predict an increased risk of coronary artery disease in Korean population.
Topics: Adult; Aged; Asian People; C-Reactive Protein; Coronary Artery Disease; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Surveys and Questionnaires; Young Adult | 2012 |
[Hyperhomocysteinemia and plasma acute-phase proteins in patients with type 2 diabetes mellitus and severe course of atherosclerosis after vascular operations].
Topics: Atherosclerosis; C-Reactive Protein; Diabetes Mellitus, Type 2; Disease Progression; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Male; Middle Aged; Postoperative Complications; Risk Assessment; Severity of Illness Index; Statistics as Topic; Vascular Surgical Procedures | 2011 |
Exposure to polycyclic aromatic hydrocarbons and serum inflammatory markers of cardiovascular disease.
Topics: Adult; Aged; Biomarkers; Cardiovascular Diseases; Female; Fibrinogen; Fluorenes; Homocysteine; Humans; Leukocyte Count; Linear Models; Male; Middle Aged; Naphthalenes; Phenanthrenes; Polycyclic Aromatic Hydrocarbons; Pyrenes; United States | 2012 |
Changes of blood platelet adhesion to collagen and fibrinogen induced by homocysteine and its thiolactone.
Topics: Adult; Analysis of Variance; Blood Platelets; Cell Adhesion; Collagen; Fibrinogen; Hemostasis; Homocysteine; Humans; Young Adult | 2012 |
A prothrombotic state is associated with early arterial damage in hypertensive patients.
Topics: Aged; Arteries; Body Mass Index; C-Reactive Protein; Cross-Sectional Studies; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Male; Middle Aged; Thrombosis | 2012 |
The polyphenol-rich extracts from black chokeberry and grape seeds impair changes in the platelet adhesion and aggregation induced by a model of hyperhomocysteinemia.
Topics: Adult; Antioxidants; Blood Platelets; Cardiovascular Diseases; Collagen; Dietary Supplements; Fibrinogen; Fruit; Grape Seed Extract; Homocysteine; Humans; Hyperhomocysteinemia; Photinia; Plant Extracts; Platelet Activation; Platelet Aggregation Inhibitors; Polyphenols; Seeds; Superoxides; Vitis; Young Adult | 2013 |
Aldosterone levels and inflammatory stimulation in essential hypertensive patients.
Topics: Adult; Aged; Aldosterone; Biomarkers; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Essential Hypertension; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Inflammation; Leukocyte Count; Male; Middle Aged; Renin; Risk Factors | 2013 |
Effects of hyperhomocysteinemia and betaine-homocysteine S-methyltransferase inhibition on hepatocyte metabolites and the proteome.
Topics: Apolipoprotein A-I; Apoptosis; Betaine-Homocysteine S-Methyltransferase; Blotting, Western; Cell Proliferation; Cells, Cultured; Colorectal Neoplasms; Electrophoresis, Gel, Two-Dimensional; Fibrinogen; Hepatocytes; Homocysteine; Humans; Hyperhomocysteinemia; Liver Neoplasms; Male; Metabolomics; Middle Aged; Protein Multimerization; Proteome; S-Adenosylmethionine; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2013 |
Differences in brain natriuretic peptide and other factors between Japanese peripheral arterial disease patients with critical limb ischemia and intermittent claudication.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Angiography; Ankle Brachial Index; Asian People; Body Mass Index; Cholesterol; Female; Fibrinogen; Glomerular Filtration Rate; Homocysteine; Humans; Intermittent Claudication; Ischemia; Japan; Leg; Male; Middle Aged; Natriuretic Peptide, Brain; Peripheral Arterial Disease; Prevalence; Risk Factors; Sex Factors; Smoking | 2013 |
Serum analysis of coagulation factors in IPF and NSIP.
Topics: Blood Coagulation; Blood Coagulation Factors; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Homocysteine; Humans; Idiopathic Interstitial Pneumonias; Idiopathic Pulmonary Fibrosis; Lupus Coagulation Inhibitor; Male; Middle Aged; Protein C; Protein S | 2014 |
Homocysteine and other cardiovascular risk factors in patients with lichen planus.
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Dyslipidemias; Female; Fibrinogen; Homocysteine; Humans; Lichen Planus; Male; Metabolic Syndrome; Middle Aged; Risk Factors | 2014 |
Cluster of cardiometabolic risk factors in children with GH deficiency: a prospective, case-control study.
Topics: Adipokines; Adiponectin; Biomarkers; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Child; Cholesterol; Female; Fibrinogen; Homocysteine; Human Growth Hormone; Humans; Inflammation; Leptin; Male; Prospective Studies; Risk Factors; Treatment Outcome | 2014 |
Beneficial effects of rosuvastatin treatment in patients with metabolic syndrome.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Fluorobenzenes; Glycated Hemoglobin; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Lipids; Male; Metabolic Syndrome; Middle Aged; Oxidative Stress; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome | 2015 |
Relation of asymmetric dimethylarginine levels to macrovascular disease and inflammation markers in type 2 diabetic patients.
Topics: Aged; Arginine; Atherosclerosis; Biomarkers; Blood Sedimentation; C-Reactive Protein; Carotid Intima-Media Thickness; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Homocysteine; Humans; Inflammation Mediators; Male; Middle Aged; Regression Analysis; Systemic Vasculitis; Up-Regulation | 2014 |
Differences in vitamin D concentration between metabolically healthy and unhealthy obese adults: associations with inflammatory and cardiometabolic markers in 4391 subjects.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Pressure; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Inflammation; Insulin Resistance; Iran; Lipids; Liver; Male; Metabolic Syndrome; Middle Aged; Obesity; Vitamin D; Waist Circumference | 2014 |
Subclinical hypothyroidism and cardiovascular risk.
Topics: Adult; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Erythrocytes; Female; Fibrinogen; Healthy Volunteers; Homocysteine; Humans; Hypothyroidism; Immunoenzyme Techniques; Inflammation; Male; Middle Aged; Regression Analysis; Risk Factors; Thyrotropin; Viscosity | 2014 |
[Atypical risk factors of atherosclerosis in patients with hypothyroidism].
Topics: Adult; Aged; Atherosclerosis; Biomarkers; Body Mass Index; C-Reactive Protein; Carotid Arteries; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Hypothyroidism; Male; Middle Aged; Risk Factors; Uric Acid | 2013 |
Influence of anti-VEGF about cardiovascular biomarkers in age related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Atherosclerosis; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Homocysteine; Humans; Lipids; Macular Degeneration; Male; Middle Aged; Ranibizumab; Risk Factors; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2015 |
Homocysteine influences blood clot properties alone and in combination with total fibrinogen but not with fibrinogen γ' in Africans.
Topics: Black People; Blood Coagulation; Cardiovascular Diseases; Cross-Sectional Studies; Fibrin Clot Lysis Time; Fibrinogen; Fibrinogens, Abnormal; Genotype; Hemostasis; Homocysteine; Humans; Polymorphism, Single Nucleotide; Risk Factors | 2015 |
Neopterin: An immune biomarker of coronary artery disease and its association with other CAD markers.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; Coronary Artery Disease; Creatine Kinase, MB Form; Female; Fibrinogen; Homocysteine; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Neopterin; Troponin | 2015 |
Comparison of risk factors for cardiovascular disease in hemodialysis and peritoneal dialysis patients.
Topics: Adult; Atherosclerosis; Blood Glucose; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Male; Metabolic Syndrome; Middle Aged; Peritoneal Dialysis; Renal Dialysis; Risk Factors; Triglycerides | 2015 |
Elevated fibrinogen and lowered homocysteine-vitamin determinants and their association with left atrial thrombus in patients with rheumatic mitral stenosis.
Topics: Adult; Biomarkers; Blood Platelets; Cross-Sectional Studies; Female; Fibrinogen; Folic Acid; Heart Atria; Homocysteine; Humans; Male; Middle Aged; Mitral Valve; Mitral Valve Stenosis; Platelet Aggregation; Rheumatic Heart Disease; Thrombosis; Ultrasonography; Vitamin B 12 | 2015 |
The Effect of Metformin and Metformin-Testosterone Combination on Cardiometabolic Risk Factors in Men with Late-onset Hypogonadism and Impaired Glucose Tolerance.
Topics: Aged; C-Reactive Protein; Cholesterol, LDL; Eunuchism; Fibrinogen; Glucose Tolerance Test; Homocysteine; Humans; Male; Metformin; Middle Aged; Risk Factors; Testosterone; Uric Acid | 2015 |
Association of exposure to particulate matter (PM2.5) air pollution and biomarkers of cardiovascular disease risk in adult NHANES participants (2001-2008).
Topics: Adult; Air Pollutants; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Environmental Exposure; Female; Fibrinogen; Homocysteine; Humans; Leukocyte Count; Male; Middle Aged; Nutrition Surveys; Ozone; Particulate Matter; Risk Factors; United States; Young Adult | 2016 |
Cardiometabolic risk markers of normal weight and excess body weight in Brazilian adolescents.
Topics: Adolescent; Biomarkers; Blood Glucose; Blood Pressure; Body Weight; Brazil; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Exercise; Female; Fibrinogen; Homocysteine; Humans; Insulin; Insulin Resistance; Leptin; Logistic Models; Male; Metabolic Syndrome; Overweight; Risk Factors; Socioeconomic Factors; Triglycerides; Tumor Necrosis Factor-alpha | 2016 |
[PROGNOSTIC VALUE OF SOME HEMOSTASIS-RELATED, HOMOCYSTEINE, HIGH SENSITIVE C R P AND MULTIDETECTOR COMPUTED TOMOGRAPHY PARAMETERS IN PULMONARY EMBOLISM].
Topics: Adolescent; Adult; Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Homocysteine; Humans; Male; Middle Aged; Multidetector Computed Tomography; Prognosis; Pulmonary Embolism; Young Adult | 2016 |
The association of uric acid with leukoaraiosis.
Topics: Aged; Aged, 80 and over; Alcohol Drinking; Asian People; Cognitive Dysfunction; Cross-Sectional Studies; Diabetes Mellitus; Dizziness; Dyslipidemias; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Headache; Homocysteine; Humans; Hypertension; Hyperuricemia; Leukoaraiosis; Male; Middle Aged; Multivariate Analysis; Risk Factors; Smoking; Uric Acid | 2017 |
The relationship between smoking intensity and subclinical cardiovascular injury: The Multi-Ethnic Study of Atherosclerosis (MESA).
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Coagulation; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Cotinine; Cross-Sectional Studies; Cytokines; Early Diagnosis; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Homocysteine; Humans; Inflammation Mediators; Linear Models; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Risk Assessment; Risk Factors; Smoking; Troponin T; United States; Vascular Stiffness; Vasodilation | 2017 |
Can Nutrition or Inflammation Moderate the Age-Cognition Association Among Older Adults?
Topics: Age Factors; Aged; beta Carotene; Biomarkers; C-Reactive Protein; Cognition; Cognitive Dysfunction; Diet; Female; Ferritins; Fibrinogen; Folic Acid; Homocysteine; Humans; Inflammation; Iron; Male; Middle Aged; Neuropsychological Tests; Nutrition Surveys; Nutritional Status; Vitamins | 2019 |
Evaluation of the Health Benefits of a Multivitamin, Multimineral, Herbal, Essential Oil-Infused Supplement: A Pilot Trial.
Topics: Adult; Arachidonic Acid; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Dietary Supplements; Eicosapentaenoic Acid; Female; Ferritins; Fibrinogen; Homocysteine; Humans; Insulin; Male; Micronutrients; Oils, Volatile; Pilot Projects; Sex Hormone-Binding Globulin; Testosterone; Triglycerides; Ubiquinone | 2018 |
Coagulation F13A1 V34L, fibrinogen and homocysteine versus conventional risk factors in the pathogenesis of MI in young persons.
Topics: Adolescent; Adult; Blood Coagulation; DNA; Factor XIIIa; Female; Fibrinogen; Follow-Up Studies; Gene Frequency; Genotype; Homocysteine; Humans; Male; Myocardial Infarction; Polymerase Chain Reaction; Polymorphism, Genetic; Retrospective Studies; Risk Factors; Young Adult | 2018 |
Structural changes of fibrinogen molecule mediated by the N-homocysteinylation reaction.
Topics: Electrophoresis, Capillary; Electrophoresis, Gel, Two-Dimensional; Fibrinogen; Homocysteine; Humans; Hydrogen-Ion Concentration; Hydrolysis; Hyperhomocysteinemia; Isoelectric Focusing | 2018 |
Homocysteine is the confounding factor of metabolic syndrome-confirmed by siMS score.
Topics: Adult; Age Factors; Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Confounding Factors, Epidemiologic; Cross-Sectional Studies; Decision Support Techniques; Dyslipidemias; Female; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation Mediators; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Middle Aged; Obesity, Abdominal; Predictive Value of Tests; Risk Factors; Up-Regulation; Uric Acid | 2018 |
COMMERCIAL EXTRACT FROM ARONIA AS A MODULATOR OF ADHESIVE PROPERTIES OF FIBRINOGEN TREATED WITH HOMOCYSTEINE AND ITS THIOLACTONE IN VITRO.
Topics: Blood Platelets; Fibrinogen; Fruit; Homocysteine; Humans; Hyperhomocysteinemia; In Vitro Techniques; Photinia; Plant Extracts; Platelet Adhesiveness; Polyphenols | 2016 |
Impact of β-thalassemia trait carrier state on inflammatory status in patients with newly diagnosed hypertension.
Topics: Aged; beta-Thalassemia; Biomarkers; Body Mass Index; C-Reactive Protein; Female; Fibrinogen; Health Status; Homocysteine; Humans; Hypertension; Inflammation; Inflammation Mediators; Leukocyte Count; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Serum Amyloid A Protein | 2019 |
Does weight loss affect the parameters that are metabolically related to cardiovascular diseases?
Topics: Adult; Aged; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diet, Reducing; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Insulin; Leptin; Male; Middle Aged; Obesity; Triglycerides; Uric Acid; Weight Loss | 2019 |
The effect of atorvastatin on cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia: A pilot study.
Topics: Adrenal Hyperplasia, Congenital; Adult; Androgens; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Dehydroepiandrosterone Sulfate; Female; Fibrinogen; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Pilot Projects; Risk Factors; Testosterone; Uric Acid; Vitamin D | 2019 |
Correlations of degree of coronary artery stenosis with blood lipid, CRP, Hcy, GGT, SCD36 and fibrinogen levels in elderly patients with coronary heart disease.
Topics: Aged; Aged, 80 and over; C-Reactive Protein; CD36 Antigens; Coronary Disease; Female; Fibrinogen; gamma-Glutamyltransferase; Homocysteine; Humans; Lipids; Male; Middle Aged | 2019 |
The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome.
Topics: Adult; Aged; Androgens; Anticholesteremic Agents; Atorvastatin; Blood Glucose; C-Reactive Protein; Cardiometabolic Risk Factors; Female; Fibrinogen; Homocysteine; Humans; Hydroxycholecalciferols; Insulin Resistance; Lipids; Male; Middle Aged; Polycystic Ovary Syndrome; Risk Factors; Testosterone; Uric Acid | 2021 |
Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson's disease patients with type 2 diabetes mellitus.
Topics: Age Factors; Aged; Biomarkers; Blood Glucose; China; Cholesterol, LDL; Dementia; Diabetes Mellitus, Type 2; Female; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Inflammation; Male; Middle Aged; Parkinson Disease; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Vascular Diseases | 2020 |
The Relationship Between Blood Hypoxia-Inducible Factor-1α, Fetuin-A, Fibrinogen, Homocysteine, and Amputation Level.
Topics: alpha-2-HS-Glycoprotein; Amputation, Surgical; Diabetic Foot; Fibrinogen; Homocysteine; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Vascular Calcification | 2022 |
Hypercoagulability in patients with indirect carotid cavernous fistulas.
Topics: Antibodies, Anticardiolipin; Antithrombin III; Atrial Fibrillation; Female; Fibrinogen; Fistula; Homocysteine; Humans; Lupus Coagulation Inhibitor; Male; Protein C; Prothrombin; Thrombophilia | 2022 |
Gut Microbiota and Coronary Plaque Characteristics.
Topics: Biomarkers; Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Fibrinogen; Gastrointestinal Microbiome; Homocysteine; Humans; Interleukin-6; Plaque, Atherosclerotic; RNA, Ribosomal, 16S; Tomography, Optical Coherence; Ultrasonography, Interventional | 2022 |
Cabergoline-Induced Hypoprolactinemia May Attenuate Cardiometabolic Effects of Atorvastatin: A Pilot Study.
Topics: Androgens; Atorvastatin; C-Reactive Protein; Cabergoline; Cardiovascular Diseases; Female; Fibrinogen; Homocysteine; Humans; Insulin Resistance; Pilot Projects; Prolactin; Risk Factors; Uric Acid | 2022 |
Biomarkers associated with coronary high-risk plaques.
Topics: Bile Acids and Salts; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Creatinine; Fibrinogen; Homocysteine; Humans; Inflammation; Interleukin-6; Plaque, Atherosclerotic; Predictive Value of Tests; Prothrombin; Tomography, Optical Coherence; Ultrasonography, Interventional | 2022 |
[Frequency and risk factors for thromboembolic complications in patients with inflammatory bowel diseases].
Topics: Colitis, Ulcerative; Contraceptive Agents; Crohn Disease; Female; Fibrinogen; Folic Acid; Homocysteine; Humans; Inflammatory Bowel Diseases; Male; Methylenetetrahydrofolate Reductase (NADPH2); Risk Factors | 2022 |
Avocado consumption and markers of inflammation: results from the Multi-Ethnic Study of Atherosclerosis (MESA).
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Diet; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Interleukins; Male; Middle Aged; Persea | 2023 |
Study on the predictive value of serum hypersensitive C-reactive protein, homocysteine, fibrinogen, and omentin-1 levels with gestational diabetes mellitus.
Topics: Blood Glucose; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Diabetes, Gestational; Female; Fibrinogen; Homocysteine; Humans; Infant; Pregnancy | 2023 |
Clinical efficacy and the influence of fibrinogen, homocysteine and prognosis in acute ischemic stroke patients treated with tirofiban plus TERVO stent thrombectomy.
Topics: Brain Ischemia; Fibrinogen; Hemostatics; Homocysteine; Humans; Ischemic Stroke; Retrospective Studies; Stents; Thrombectomy; Tirofiban; Treatment Outcome | 2023 |